<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="nlm-ta">PLoS Biol</journal-id>
<journal-id journal-id-type="pmc">plosbiol</journal-id><journal-title-group>
<journal-title>PLoS Biology</journal-title></journal-title-group>
<issn pub-type="ppub">1544-9173</issn>
<issn pub-type="epub">1545-7885</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PBIOLOGY-D-13-02470</article-id>
<article-id pub-id-type="doi">10.1371/journal.pbio.1001791</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology</subject><subj-group><subject>Developmental biology</subject><subj-group><subject>Molecular development</subject><subj-group><subject>Signaling</subject></subj-group></subj-group><subj-group><subject>Cell differentiation</subject></subj-group></subj-group><subj-group><subject>Genetics</subject><subj-group><subject>Epigenetics</subject><subj-group><subject>Chromatin</subject></subj-group></subj-group></subj-group><subj-group><subject>Immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group><subj-group><subject>Genetics of the immune system</subject></subj-group></subj-group><subj-group><subject>Molecular cell biology</subject><subj-group><subject>Chromosome biology</subject><subj-group><subject>Chromatin</subject></subj-group></subj-group><subj-group><subject>Gene expression</subject><subj-group><subject>Chromatin</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Clinical immunology</subject><subj-group><subject>Immune cells</subject><subj-group><subject>B cells</subject></subj-group></subj-group><subj-group><subject>Immunity</subject><subj-group><subject>Humoral immunity</subject><subject>Immune deficiency</subject></subj-group></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Pre-B Cell Receptor Signaling Induces Immunoglobulin κ Locus Accessibility by Functional Redistribution of Enhancer-Mediated Chromatin Interactions</article-title>
<alt-title alt-title-type="running-head">Pre-BCR Signaling and Igκ Locus Topology</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Stadhouders</surname><given-names>Ralph</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>de Bruijn</surname><given-names>Marjolein J. W.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rother</surname><given-names>Magdalena B.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yuvaraj</surname><given-names>Saravanan</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>de Almeida</surname><given-names>Claudia Ribeiro</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="fn" rid="fn1"><sup>¤</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kolovos</surname><given-names>Petros</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Van Zelm</surname><given-names>Menno C.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>van Ijcken</surname><given-names>Wilfred</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Grosveld</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soler</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hendriks</surname><given-names>Rudi W.</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Cell Biology, Erasmus MC Rotterdam, The Netherlands</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Pulmonary Medicine, Erasmus MC Rotterdam, The Netherlands</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Immunology, Erasmus MC Rotterdam, The Netherlands</addr-line></aff>
<aff id="aff4"><label>4</label><addr-line>Center for Biomics, Erasmus MC Rotterdam, The Netherlands</addr-line></aff>
<aff id="aff5"><label>5</label><addr-line>The Cancer Genomics Center, Erasmus MC Rotterdam, The Netherlands</addr-line></aff>
<aff id="aff6"><label>6</label><addr-line>INSERM UMR967 and French Alternative Energies and Atomic Energy Commission (CEA), Fontenay-aux-Roses, France</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Nemazee</surname><given-names>David</given-names></name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>Scripps Research Institute, United States of America</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">r.hendriks@erasmusmc.nl</email></corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>The author(s) have made the following declarations about their contributions: Conceived and designed the experiments: RS MVZ ES FG RWH. Performed the experiments: RS MJWdB MBR CRdA. Analyzed the data: RS RWH MBR SY WvIJ PK. Wrote the paper: RS RWH.</p></fn>
<fn id="fn1" fn-type="current-aff"><label>¤</label><p>Current address: Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom.</p></fn>
</author-notes>
<pub-date pub-type="collection"><month>2</month><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>18</day><month>2</month><year>2014</year></pub-date>
<volume>12</volume>
<issue>2</issue>
<elocation-id>e1001791</elocation-id>
<history>
<date date-type="received"><day>21</day><month>6</month><year>2013</year></date>
<date date-type="accepted"><day>8</day><month>1</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Stadhouders et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract abstract-type="toc"><sec>
<title/>
<p>Chromatin conformation analyses provide novel insights into how variable segments in the immunoglobulin light chain gene become accessible for recombination in precursor B lymphocytes.</p>
</sec></abstract>
<abstract>
<p>During B cell development, the precursor B cell receptor (pre-BCR) checkpoint is thought to increase immunoglobulin <italic>κ</italic> light chain (<italic>Igκ</italic>) locus accessibility to the V(D)J recombinase. Accordingly, pre-B cells lacking the pre-BCR signaling molecules Btk or Slp65 showed reduced germline V<sub>κ</sub> transcription. To investigate whether pre-BCR signaling modulates V<sub>κ</sub> accessibility through enhancer-mediated <italic>Igκ</italic> locus topology, we performed chromosome conformation capture and sequencing analyses. These revealed that already in pro-B cells the κ enhancers robustly interact with the ∼3.2 Mb V<sub>κ</sub> region and its flanking sequences. Analyses in wild-type, Btk, and Slp65 single- and double-deficient pre-B cells demonstrated that pre-BCR signaling reduces interactions of both enhancers with <italic>Igκ</italic> locus flanking sequences and increases interactions of the 3′κ enhancer with V<sub>κ</sub> genes. Remarkably, pre-BCR signaling does not significantly affect interactions between the intronic enhancer and V<sub>κ</sub> genes, which are already robust in pro-B cells. Both enhancers interact most frequently with highly used V<sub>κ</sub> genes, which are often marked by transcription factor E2a. We conclude that the κ enhancers interact with the V<sub>κ</sub> region already in pro-B cells and that pre-BCR signaling induces accessibility through a functional redistribution of long-range chromatin interactions within the V<sub>κ</sub> region, whereby the two enhancers play distinct roles.</p>
</abstract>
<abstract abstract-type="summary"><title>Author Summary</title>
<p>B lymphocyte development involves the generation of a functional antigen receptor, comprising two heavy chains and two light chains arranged in a characteristic “Y” shape. To do this, the receptor genes must first be assembled by ordered genomic recombination events, starting with the immunoglobulin heavy chain (IgH) gene segments. On successful rearrangement, the resulting IgH μ protein is presented on the cell surface as part of a preliminary version of the B cell receptor—the “pre-BCR.” Pre-BCR signaling then redirects recombination activity to the immunoglobulin κ light chain gene. The activity of two regulatory κ enhancer elements is known to be crucial for opening up the gene, but it remains largely unknown how the hundred or so Variable (V) segments in the κ locus gain access to the recombination system. Here, we studied a panel of pre-B cells from mice lacking specific signaling molecules, reflecting absent, partial, or complete pre-BCR signaling. We identify gene regulatory changes that are dependent on pre-BCR signaling and occur via long-range chromatin interactions between the κ enhancers and the V segments. Surprisingly the light chain gene initially contracts, but the interactions then become more functionally redistributed when pre-BCR signaling occurs. Interestingly, we find that the two enhancers play distinct roles in the process of coordinating chromatin interactions towards the V segments. Our study combines chromatin conformation techniques with data on transcription factor binding to gain unique insights into the functional role of chromatin dynamics.</p>
</abstract>
<funding-group><funding-statement>This work was partly supported by Fundação para a Ciência e a Tecnologia (to CRA), the International Association for Cancer Research (AICR 10-0562, to RWH), EpiGenSys/ERASysBio +/FP7 (NL: NWO, UK: BSRC, D: BMBF, to PK), the Center of Biomedical Genetics and the EU 6th Framework Programme EuTRACC Consortium (Project LSHG-CT-2007-037455; FG, ES, and RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="19"/></counts></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>B lymphocyte development is characterized by stepwise recombination of immunoglobulin (Ig), variable (V), diversity (D), and joining (J) genes, whereby in pro-B cells the Ig heavy (H) chain locus rearranges before the <italic>Igκ</italic> or <italic>Igλ</italic> light (L) chain loci <xref ref-type="bibr" rid="pbio.1001791-Jung1">[1]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Bossen1">[2]</xref>. Productive <italic>IgH</italic> chain rearrangement is monitored by deposition of the <italic>IgH</italic> μ chain protein on the cell surface, together with the preexisting surrogate light chain (SLC) proteins λ5 and VpreB, as the pre-B cell receptor (pre-BCR) complex <xref ref-type="bibr" rid="pbio.1001791-Herzog1">[3]</xref>. Pre-BCR expression serves as a checkpoint that monitors for functional <italic>IgH</italic> chain rearrangement, triggers proliferative expansion, and induces developmental progression of large cycling into small resting Ig μ<sup>+</sup> pre-B cells in which the recombination machinery is reactivated for rearrangement of the <italic>Igκ</italic> or <italic>Igλ</italic> L chain loci <xref ref-type="bibr" rid="pbio.1001791-Herzog1">[3]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Hendriks1">[4]</xref>.</p>
<p>During the V(D)J recombination process, the spatial organization of large antigen receptor loci is actively remodeled <xref ref-type="bibr" rid="pbio.1001791-Jhunjhunwala1">[5]</xref>. Overall locus contraction is achieved through long-range chromatin interactions between proximal and distal regions within these loci. This process brings distal V genes in close proximity to (D)J regions, to which Rag (recombination activating gene) protein binding occurs <xref ref-type="bibr" rid="pbio.1001791-Ji1">[6]</xref> and the nearby regulatory elements that are required for topological organization and recombination <xref ref-type="bibr" rid="pbio.1001791-Jhunjhunwala1">[5]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Perlot1">[7]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Cobb1">[8]</xref>. The recombination-associated changes in locus topology thereby provide equal opportunities for individual V genes to be recombined to a (D)J segment. Accessibility and recombination of antigen receptor loci are controlled by many DNA-binding factors that interact with local <italic>cis</italic>-regulatory elements, such as promoters, enhancers, or silencers <xref ref-type="bibr" rid="pbio.1001791-Perlot1">[7]</xref>–<xref ref-type="bibr" rid="pbio.1001791-Oestreich1">[9]</xref>. The long-range chromatin interactions involved in this process are thought to be crucial for the regulation of V(D)J recombination and orchestrate changes in subnuclear relocation, germline transcription, histone acetylation and/or methylation, DNA demethylation, and compaction of antigen receptor loci <xref ref-type="bibr" rid="pbio.1001791-Jhunjhunwala1">[5]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Seitan1">[10]</xref>.</p>
<p>The mouse <italic>Igκ</italic> locus harbors 101 functional V<sub>κ</sub> genes and four functional J<sub>κ</sub> elements and is spread over &gt;3 Mb of genomic DNA <xref ref-type="bibr" rid="pbio.1001791-Lefranc1">[11]</xref>. Mechanisms regulating the site-specific DNA recombination reactions that create a diverse <italic>Igκ</italic> repertoire are complex and involve local differences in the accessibility of the V<sub>κ</sub> and J<sub>κ</sub> genes to the recombinase proteins <xref ref-type="bibr" rid="pbio.1001791-Yancopoulos1">[12]</xref>. Developmental-stage-specific changes in gene accessibility are reflected by germline transcription, which precedes or accompanies gene recombination <xref ref-type="bibr" rid="pbio.1001791-Abarrategui1">[13]</xref>. In the <italic>Igκ</italic> locus, germline transcription is initiated from promoters located upstream of J<sub>κ</sub> (referred to as κ<sup>0</sup> transcripts) and from V<sub>κ</sub> promoters <xref ref-type="bibr" rid="pbio.1001791-Schlissel1">[14]</xref>. Deletion of the intronic enhancer (iEκ), located between J<sub>κ</sub> and C<sub>κ</sub>, or the downstream 3′κ enhancer (3′Eκ), both containing binding sites for the E2a and Irf4/Irf8 transcription factors (TFs), diminishes <italic>Igκ</italic> locus germline transcription and recombination <xref ref-type="bibr" rid="pbio.1001791-Murre1">[15]</xref>–<xref ref-type="bibr" rid="pbio.1001791-Johnson1">[19]</xref>. On the other hand, the Sis (silencer in intervening sequence) element in the V<sub>κ</sub>–J<sub>κ</sub> region negatively regulates <italic>Igκ</italic> rearrangement <xref ref-type="bibr" rid="pbio.1001791-Liu1">[20]</xref>. This Sis element was shown to target <italic>Igκ</italic> alleles to centromeric heterochromatin and to associate with the Ikaros repressor protein that also colocalizes with centromeric heterochromatin. Sis contains a strong binding site for the zinc-finger transcription regulator CTCC-binding factor (Ctcf) <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>,<xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida2">[22]</xref>. Interestingly, deletion of the Sis element or conditional deletion of the <italic>Ctcf</italic> gene in the B cell lineage both resulted in reduced κ<sup>0</sup> germline transcription and enhanced proximal V<sub>κ</sub> usage <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Xiang1">[23]</xref>. Very recently, a novel Ctcf binding element located directly upstream of the Sis region was shown to be essential for locus contraction and recombination to distal V<sub>κ</sub> genes <xref ref-type="bibr" rid="pbio.1001791-Xiang1">[23]</xref>. In addition, the <italic>Igκ</italic> repertoire is controlled by the polycomb group protein YY1 <xref ref-type="bibr" rid="pbio.1001791-Pan1">[24]</xref>.</p>
<p>Induction of <italic>Igκ</italic> rearrangements requires the expression of the Rag1 and Rag2 proteins, the attenuation of the cell cycle, and transcriptional activation of the <italic>Igκ</italic> locus, all of which are thought to be crucially dependent on pre-BCR signaling <xref ref-type="bibr" rid="pbio.1001791-Hendriks1">[4]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Melchers1">[25]</xref>. At first, pre-BCR signals synergize with interleukin-7 receptor (IL-7R) signals to drive proliferative expansion of IgH μ<sup>+</sup> large pre-B cells <xref ref-type="bibr" rid="pbio.1001791-Hendriks1">[4]</xref>. In these cells, transcription of the <italic>Rag</italic> genes is low and the Rag2 protein is unstable due to cell-cycle-dependent degradation <xref ref-type="bibr" rid="pbio.1001791-Li1">[26]</xref>. Subsequently, signaling through the pre-BCR downstream adapter Slp65 (SH2-domain-containing leukocyte protein of 65 kDa, also known as Blnk or Bash) switches cell fate from proliferation to differentiation <xref ref-type="bibr" rid="pbio.1001791-Hendriks1">[4]</xref>. Importantly, Slp65 (i) induces the TF Aiolos, which down-regulates λ5 expression <xref ref-type="bibr" rid="pbio.1001791-Thompson1">[27]</xref>; (ii) binds Jak3 and thereby interferes with IL-7R signaling <xref ref-type="bibr" rid="pbio.1001791-Nakayama1">[28]</xref>; and (iii) reduces inhibitory phosphorylation of Foxo TFs <xref ref-type="bibr" rid="pbio.1001791-Herzog2">[29]</xref>. All these changes result in attenuation of the cell cycle and thus Rag protein stabilization. Moreover, <italic>Rag</italic> gene transcription is induced by Foxo proteins <xref ref-type="bibr" rid="pbio.1001791-Amin1">[30]</xref>.</p>
<p>Although rearrangement and expression of the <italic>Igκ</italic> locus can occur independently of IgH μ chain expression <xref ref-type="bibr" rid="pbio.1001791-Novobrantseva1">[31]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Melchers2">[32]</xref>, several lines of evidence indicate that pre-BCR signaling is actively involved in inducing <italic>Igκ</italic> and <italic>Igλ</italic> locus accessibility and gene rearrangement. First, surface IgH μ chain expression correlates with germline transcription in the <italic>Igκ</italic> locus <xref ref-type="bibr" rid="pbio.1001791-Schlissel2">[33]</xref>. Second, in the absence of Slp65, κ<sup>0</sup> germline transcription is reduced <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>. Third, mice deficient for Bruton's tyrosine kinase (Btk), which is a pre-BCR downstream signaling molecule interacting with Slp65, show reduced <italic>Igλ</italic> L chain germline transcription and reduced Igλ usage <xref ref-type="bibr" rid="pbio.1001791-Dingjan1">[35]</xref>. Fourth, transgenic expression of the constitutively active E41K-Btk mutant in IgH μ chain negative pro-B cells induces premature rearrangement and protein expression of Igκ L chain <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>. Based on fluorescence in situ hybridization (FISH) studies, it has been proposed that in pro-B cells distal Vκ and Cκ genes are separated by large distances and that the <italic>Igκ</italic> locus specifically undergoes contraction in small pre-B and immature B cells actively undergoing V<sub>κ</sub>-J<sub>κ</sub> recombination <xref ref-type="bibr" rid="pbio.1001791-Roldan1">[36]</xref>. However, it remains unknown how pre-BCR-induced signals affect the accessibility, contraction, and topology of the Vκ region, or how they affect the long-range interactions of the κ regulatory elements involved in organizing these events.</p>
<p>In this study, we identified the effects of pre-BCR signaling on germline Vκ transcription and on the expression of TFs implicated in the regulation of <italic>Igκ</italic> gene rearrangement. We found that the decrease in pre-BCR signaling capacity in wild-type, Btk-deficient, Slp65-deficient, and Btk/Slp65 double-deficient pre-B cells was paralleled by a gradient of decreased expression of many TFs including Ikaros, Aiolos, Irf4, and (to a lesser extent) E2a, as well as by a decreased <italic>Igκ</italic> locus accessibility for recombination. Several of these factors can mediate long-range chromatin interactions and are known to occupy κ regulatory elements that regulate locus accessibility <xref ref-type="bibr" rid="pbio.1001791-Inlay1">[37]</xref>–<xref ref-type="bibr" rid="pbio.1001791-Lin1">[40]</xref>. We therefore sought to analyze the effect of pre-BCR signaling on the higher order chromatin structure organized by these regulatory sequences at the <italic>Igκ</italic> locus. To this end, we performed chromosome conformation capture and sequencing (3C-seq) analyses <xref ref-type="bibr" rid="pbio.1001791-Stadhouders1">[41]</xref> on pro-B cells and pre-B cells from mice single or double deficient for Btk or Slp65 to evaluate the effects of this pre-BCR signaling gradient on <italic>Igκ</italic> locus topology. These 3C-seq experiments demonstrated that already in pro-B cells the κ enhancers robustly interact with the ∼3.2 Mb Vκ region and its flanking sequences, and that pre-BCR signaling induces accessibility by a functional redistribution of enhancer-mediated chromatin interactions within the V<sub>κ</sub> region.</p>
</sec><sec id="s2">
<title>Results</title>
<sec id="s2a">
<title>Identification of Genes Regulated by Pre-BCR Signaling</title>
<p>Whereas mice deficient for the pre-BCR signaling molecules Btk and Slp65 have a partial block at the pre-B cell stage <xref ref-type="bibr" rid="pbio.1001791-Jumaa1">[42]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Middendorp1">[43]</xref>, in Btk/Slp65 double-deficient mice, only very few pre-B cells show progression to the immature B cell stage characterized by functional <italic>IgL</italic> chain gene recombination <xref ref-type="bibr" rid="pbio.1001791-Jumaa2">[44]</xref>. To enable analysis of the effects of pre-BCR signaling on (i) the expression of genes involved in <italic>Igκ</italic> gene rearrangement and on (ii) long-distance chromatin interactions in the <italic>Igκ</italic> locus in pre-B cells in the absence of <italic>Igκ</italic> gene recombination events, we bred Btk and Slp65 single- and double-deficient mice on the <italic>Rag1</italic><sup>−/−</sup> background. In these mice, progression of B cell progenitors to the pre-B cell stage was conferred by the transgenic, functionally rearranged VH81x IgH μ chain, which ensures pre-BCR expression and cellular proliferation. The absence of functional Rag1 protein precludes <italic>IgL</italic> chain gene rearrangement and cells are completely arrested at the small pre-B cell stage (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1A</xref>).</p>
<fig id="pbio-1001791-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g001</object-id><label>Figure 1</label><caption>
<title>Gene expression profiling strategy for the identification of genes regulated by Btk/Slp65-mediated pre-BCR signaling.</title>
<p>(A) FACS sorting strategy for purification of pre-B cell fractions from the indicated mice on a VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> background. Lymphocytes were gated on the basis of forward/side scatter and B220<sup>+</sup>CD19<sup>+</sup> pre-B cell fractions were sorted. Virtually all B220<sup>+</sup>CD19<sup>+</sup> cells were cytoplasmic μ heavy chain positive <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>, but showed genotype-dependent levels of expression of the CD2 differentiation marker, in agreement with previous findings <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>. (B) DNA microarray analysis of total mRNA from FACS-purified B220<sup>+</sup>CD19<sup>+</sup> pre-B/pro-B cell fractions from the indicated mice. One-way ANOVA analysis (<italic>p</italic> = 0.01) identified 266 significantly different genes. MeV hierarchical clustering of gene expression differences are represented in the heatmap. (C) Validation of the expression of TFs implicated in <italic>Igκ</italic> gene rearrangement. Total mRNA isolated from FACS-sorted B220<sup>+</sup>CD19<sup>+</sup> pre-B/pro-B cell fractions from the indicated mice was analyzed by quantitative RT-PCR for expression of TFs. Expression levels were normalized to those of <italic>Gapdh</italic>, whereby the values in WT pre-B cells were set to one. Bars represent mean values and error bars denote standard deviations for four independent mice per group.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g001" position="float" xlink:type="simple"/></fig>
<p>We performed genome-wide expression profiling of FACS-purified B220<sup>+</sup>CD19<sup>+</sup> pre-B cell fractions from wild-type (WT), Btk, and Slp65 single- and double-deficient VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> mice (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1A</xref>). In these experiments non-VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pro-B cells served as controls. One-way ANOVA analysis using MeV software (<italic>p</italic>&lt;0.01) <xref ref-type="bibr" rid="pbio.1001791-Saeed1">[45]</xref> revealed that 266 genes were differentially expressed between the five groups of pro-B/pre-B cells (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1B</xref>). When compared with WT VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pre-B cells, 174 genes were up-regulated, whereby the average values of the fold increase were ∼1.70, ∼3.28, ∼3.36, and ∼3.47 for <italic>Btk</italic><sup>−/−</sup>, <italic>Slp65</italic><sup>−/−</sup>, <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pre-B cells and non-VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pro-B cells, respectively (see <xref ref-type="supplementary-material" rid="pbio.1001791.s010">Table S1</xref>). A similar gradient of gene expression changes was apparent from the average values of the fold change for the 192 significantly down-regulated genes, which were ∼1.65, ∼2.29, ∼3.79, and ∼4.15 in the four groups of pre-B/pro-B cells, respectively (see <xref ref-type="supplementary-material" rid="pbio.1001791.s011">Table S2</xref>). In a hierarchical clustering analysis of the five groups of B cell precursors, the expression profiles of <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pre-B cells and non-VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pro-B cells were very similar (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1B</xref>). This implies that expression of the 266 genes is not substantially influenced by pre-BCR-mediated proliferation, which is still induced in pre-B cells lacking both Btk and Slp65 <xref ref-type="bibr" rid="pbio.1001791-Jumaa2">[44]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Kersseboom2">[46]</xref> but not in <italic>Rag1</italic><sup>−/−</sup> pro-B cells. Consistent with these findings, gene distance matrix analysis revealed a clear gene expression gradient among the five groups of pre-B/pro-B cells, in which <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B and <italic>Rag1</italic><sup>−/−</sup> pro-B cells again showed highly comparably expression signatures (<xref ref-type="supplementary-material" rid="pbio.1001791.s001">Figure S1</xref>).</p>
<p>In agreement with previous findings <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Middendorp1">[43]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Kersseboom2">[46]</xref>, pre-BCR signaling-defective pre-B cells manifested increased expression of <italic>Dntt</italic>, encoding terminal deoxynucleotidyl transferase and the SLC components Vpre (<italic>Vpreb1</italic>) and λ5 (<italic>Igll1</italic>), as well as decreased expression of the cell surface markers Cd2, Cd22, Cd25(IL-2R), and MHC class II (<xref ref-type="table" rid="pbio-1001791-t001">Table 1</xref>). <italic>Btk</italic> and <italic>Slp65</italic> single-deficient and particularly double-deficient pre-B cells failed to up-regulate various genes known to be involved in <italic>IgL</italic> chain recombination, such as <italic>Ikzf3</italic> (Aiolos), <italic>Ikzf1</italic> (Ikaros), <italic>Irf4</italic>, <italic>Spib</italic>, <italic>Pou2f2</italic> (Oct2), polymerase-μ <xref ref-type="bibr" rid="pbio.1001791-Bertocci1">[47]</xref>, as well as <italic>Hivep1</italic> encoding the Mbp-1 protein, which has been shown to bind to the κ enhancers <xref ref-type="bibr" rid="pbio.1001791-Baldwin1">[48]</xref>. In addition, pre-BCR signaling influenced the expression levels of many other DNA-binding or modifying factors that were not previously associated with <italic>IgL</italic> chain recombination, including <italic>Lmo4</italic>, <italic>Zfp710</italic>, <italic>Arid1a/3a/3b</italic>, the lysine-specific demethylases <italic>Aof1</italic> and <italic>Phf2</italic>, <italic>Prdm2</italic> (a H3K9 methyltransferase), the <italic>sik1</italic> gene encoding a histon deacetylase (HDAC) kinase, <italic>Hdac5</italic>, <italic>Hdac8</italic>, and the DNA repair protein gene <italic>Rev1</italic> (<xref ref-type="supplementary-material" rid="pbio.1001791.s011">Table S2</xref>). We did not find significant differences in the expression of several other TFs implicated in Ig gene recombination—for example, Obf1/Oca-B, Pax5, E2a, and Irf8 (<xref ref-type="table" rid="pbio-1001791-t001">Table 1</xref>). In addition, in signaling-deficient pre-B cells, we found reduced transcription of genes encoding several signaling molecules (e.g., <italic>Rasgrp1</italic>, <italic>Rapgefl1</italic>, <italic>Ralgps2</italic>, <italic>Blk</italic>, <italic>Traf5</italic>, <italic>Hck</italic>, <italic>Nfkbia</italic> (IκBα), <italic>Syk</italic>, <italic>Csk</italic>), cell surface markers (Cd38, Cd72, Cd74, Cd55, and Notch2), or genes regulating cell survival (<italic>Bmf</italic> and <italic>Bcl2l1</italic> encoding Bcl<sub>XL</sub>) (<xref ref-type="supplementary-material" rid="pbio.1001791.s011">Table S2</xref>). Interestingly, we observed concomitant up-regulation of signaling molecules that are also associated with the T cell receptor (<italic>Lat</italic>, <italic>Zap70</italic>, and <italic>Prkcq</italic> (PKCθ); <xref ref-type="supplementary-material" rid="pbio.1001791.s010">Table S1</xref>).</p>
<table-wrap id="pbio-1001791-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.t001</object-id><label>Table 1</label><caption>
<title>Genes differentially expressed between WT, Btk, or Slp65 single or double mutant V<sub>H</sub>81X Tg <italic>Rag1</italic><sup>−/−</sup> pre-B cells or <italic>Rag1</italic><sup>−/−</sup> pro-B cells.</title>
</caption><alternatives><graphic id="pbio-1001791-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">ID Probe Set</td>
<td align="left" rowspan="1" colspan="1">Accession Number</td>
<td align="left" rowspan="1" colspan="1">Gene</td>
<td align="left" rowspan="1" colspan="1">Description of Function</td>
<td align="left" rowspan="1" colspan="1"><italic>p</italic> Value<xref ref-type="table-fn" rid="nt101">a</xref></td>
<td align="left" rowspan="1" colspan="1">Fold Change (Btk KO<xref ref-type="table-fn" rid="nt102">b</xref>)</td>
<td align="left" rowspan="1" colspan="1">Fold Change (Slp65 KO)</td>
<td align="left" rowspan="1" colspan="1">Fold Change (BtkSlp65 KO)</td>
<td align="left" rowspan="1" colspan="1">Fold Change (Rag1 KO)</td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="9" align="left" rowspan="1"><italic>Genes known to be up-regulated in signaling-deficient pre-B cells</italic></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10463123</td>
<td align="left" rowspan="1" colspan="1">NM_009345</td>
<td align="left" rowspan="1" colspan="1">Dntt</td>
<td align="left" rowspan="1" colspan="1">N addition VDJ recombination</td>
<td align="left" rowspan="1" colspan="1">4.26E-08</td>
<td align="left" rowspan="1" colspan="1">8.46</td>
<td align="left" rowspan="1" colspan="1">16.99</td>
<td align="left" rowspan="1" colspan="1">22.49</td>
<td align="left" rowspan="1" colspan="1">39.19</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10438064</td>
<td align="left" rowspan="1" colspan="1">NM_016982</td>
<td align="left" rowspan="1" colspan="1">Vpreb1</td>
<td align="left" rowspan="1" colspan="1">VpreB SLC component</td>
<td align="left" rowspan="1" colspan="1">7.58E-06</td>
<td align="left" rowspan="1" colspan="1">5.52</td>
<td align="left" rowspan="1" colspan="1">6.80</td>
<td align="left" rowspan="1" colspan="1">6.32</td>
<td align="left" rowspan="1" colspan="1">5.73</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10438060</td>
<td align="left" rowspan="1" colspan="1">ENSMUST00000100136</td>
<td align="left" rowspan="1" colspan="1">Igll1</td>
<td align="left" rowspan="1" colspan="1">λ5 SLC component</td>
<td align="left" rowspan="1" colspan="1">2.17E-04</td>
<td align="left" rowspan="1" colspan="1">3.38</td>
<td align="left" rowspan="1" colspan="1">3.81</td>
<td align="left" rowspan="1" colspan="1">4.17</td>
<td align="left" rowspan="1" colspan="1">3.69</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10427628</td>
<td align="left" rowspan="1" colspan="1">NM_008372</td>
<td align="left" rowspan="1" colspan="1">Il7r</td>
<td align="left" rowspan="1" colspan="1">IL-7 cytokine receptor</td>
<td align="left" rowspan="1" colspan="1">n.s.<xref ref-type="table-fn" rid="nt104">c</xref></td>
<td align="left" rowspan="1" colspan="1">1.08</td>
<td align="left" rowspan="1" colspan="1">1.62</td>
<td align="left" rowspan="1" colspan="1">1.56</td>
<td align="left" rowspan="1" colspan="1">1.91</td>
</tr>
<tr>
<td colspan="9" align="left" rowspan="1"><italic>Genes known to be down-regulated in signaling-deficient pre-B cells</italic></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10500677</td>
<td align="left" rowspan="1" colspan="1">NM_013486</td>
<td align="left" rowspan="1" colspan="1">Cd2</td>
<td align="left" rowspan="1" colspan="1">cell adhesion</td>
<td align="left" rowspan="1" colspan="1">2.57E-04</td>
<td align="left" rowspan="1" colspan="1">−4.82</td>
<td align="left" rowspan="1" colspan="1">−5.35</td>
<td align="left" rowspan="1" colspan="1">−20.52</td>
<td align="left" rowspan="1" colspan="1">−24.26</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10469278</td>
<td align="left" rowspan="1" colspan="1">NM_008367</td>
<td align="left" rowspan="1" colspan="1">Il2ra</td>
<td align="left" rowspan="1" colspan="1">IL2 cytokine receptor CD25</td>
<td align="left" rowspan="1" colspan="1">1.60E-03</td>
<td align="left" rowspan="1" colspan="1">−5.21</td>
<td align="left" rowspan="1" colspan="1">−8.79</td>
<td align="left" rowspan="1" colspan="1">−15.90</td>
<td align="left" rowspan="1" colspan="1">−16.26</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10450154</td>
<td align="left" rowspan="1" colspan="1">NM_010378</td>
<td align="left" rowspan="1" colspan="1">H2-Aa</td>
<td align="left" rowspan="1" colspan="1">MHC class II</td>
<td align="left" rowspan="1" colspan="1">1.45E-04</td>
<td align="left" rowspan="1" colspan="1">−2.04</td>
<td align="left" rowspan="1" colspan="1">−5.75</td>
<td align="left" rowspan="1" colspan="1">−13.16</td>
<td align="left" rowspan="1" colspan="1">−19.80</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10562132</td>
<td align="left" rowspan="1" colspan="1">NM_001043317</td>
<td align="left" rowspan="1" colspan="1">Cd22</td>
<td align="left" rowspan="1" colspan="1">Siglec- family receptor</td>
<td align="left" rowspan="1" colspan="1">3.32E-05</td>
<td align="left" rowspan="1" colspan="1">1.29</td>
<td align="left" rowspan="1" colspan="1">1.14</td>
<td align="left" rowspan="1" colspan="1">−1.98</td>
<td align="left" rowspan="1" colspan="1">−6.06</td>
</tr>
<tr>
<td colspan="9" align="left" rowspan="1"><italic>Transcription regulators and V(D)J recombination</italic></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10390640</td>
<td align="left" rowspan="1" colspan="1">NM_011771</td>
<td align="left" rowspan="1" colspan="1">Ikzf3</td>
<td align="left" rowspan="1" colspan="1">Aiolos DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">7.05E-08</td>
<td align="left" rowspan="1" colspan="1">−1.66</td>
<td align="left" rowspan="1" colspan="1">−3.99</td>
<td align="left" rowspan="1" colspan="1">−29.34</td>
<td align="left" rowspan="1" colspan="1">−26.09</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10384020</td>
<td align="left" rowspan="1" colspan="1">NM_017401</td>
<td align="left" rowspan="1" colspan="1">Polm</td>
<td align="left" rowspan="1" colspan="1">Polumerase mu</td>
<td align="left" rowspan="1" colspan="1">2.35E-06</td>
<td align="left" rowspan="1" colspan="1">−1.91</td>
<td align="left" rowspan="1" colspan="1">−4.17</td>
<td align="left" rowspan="1" colspan="1">−10.09</td>
<td align="left" rowspan="1" colspan="1">−12.25</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10502510</td>
<td align="left" rowspan="1" colspan="1">NM_010723</td>
<td align="left" rowspan="1" colspan="1">Lmo4</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">1.70E-03</td>
<td align="left" rowspan="1" colspan="1">−1.90</td>
<td align="left" rowspan="1" colspan="1">−3.56</td>
<td align="left" rowspan="1" colspan="1">−5.70</td>
<td align="left" rowspan="1" colspan="1">−7.22</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10404389</td>
<td align="left" rowspan="1" colspan="1">NM_013674</td>
<td align="left" rowspan="1" colspan="1">Irf4</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">7.87E-05</td>
<td align="left" rowspan="1" colspan="1">−1.60</td>
<td align="left" rowspan="1" colspan="1">−2.16</td>
<td align="left" rowspan="1" colspan="1">−4.75</td>
<td align="left" rowspan="1" colspan="1">−5.29</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10438415</td>
<td align="left" rowspan="1" colspan="1">ENSMUST00000103752</td>
<td align="left" rowspan="1" colspan="1">Igl-V2</td>
<td align="left" rowspan="1" colspan="1">Ig V lambda light chain</td>
<td align="left" rowspan="1" colspan="1">6.90E-05</td>
<td align="left" rowspan="1" colspan="1">−3.41</td>
<td align="left" rowspan="1" colspan="1">−3.87</td>
<td align="left" rowspan="1" colspan="1">−4.57</td>
<td align="left" rowspan="1" colspan="1">−4.81</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10438405</td>
<td align="left" rowspan="1" colspan="1">M94350</td>
<td align="left" rowspan="1" colspan="1">Igl-V1</td>
<td align="left" rowspan="1" colspan="1">Ig V lambda light chain</td>
<td align="left" rowspan="1" colspan="1">1.58E-06</td>
<td align="left" rowspan="1" colspan="1">−3.42</td>
<td align="left" rowspan="1" colspan="1">−3.07</td>
<td align="left" rowspan="1" colspan="1">−3.98</td>
<td align="left" rowspan="1" colspan="1">−6.20</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10562812</td>
<td align="left" rowspan="1" colspan="1">NM_019866</td>
<td align="left" rowspan="1" colspan="1">Spib</td>
<td align="left" rowspan="1" colspan="1">Spi-B DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">3.88E-04</td>
<td align="left" rowspan="1" colspan="1">−1.57</td>
<td align="left" rowspan="1" colspan="1">−1.94</td>
<td align="left" rowspan="1" colspan="1">−3.16</td>
<td align="left" rowspan="1" colspan="1">−3.22</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10364559</td>
<td align="left" rowspan="1" colspan="1">NM_007880</td>
<td align="left" rowspan="1" colspan="1">Arid3a</td>
<td align="left" rowspan="1" colspan="1">Bright DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">1.10E-03</td>
<td align="left" rowspan="1" colspan="1">−1.80</td>
<td align="left" rowspan="1" colspan="1">−2.16</td>
<td align="left" rowspan="1" colspan="1">−3.04</td>
<td align="left" rowspan="1" colspan="1">−3.18</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10594001</td>
<td align="left" rowspan="1" colspan="1">NM_019689</td>
<td align="left" rowspan="1" colspan="1">Arid3b</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">5.74E-04</td>
<td align="left" rowspan="1" colspan="1">−1.79</td>
<td align="left" rowspan="1" colspan="1">−2.51</td>
<td align="left" rowspan="1" colspan="1">−2.91</td>
<td align="left" rowspan="1" colspan="1">−3.53</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10554370</td>
<td align="left" rowspan="1" colspan="1">NM_175433</td>
<td align="left" rowspan="1" colspan="1">Zfp710</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">9.03E-03</td>
<td align="left" rowspan="1" colspan="1">−1.50</td>
<td align="left" rowspan="1" colspan="1">−1.64</td>
<td align="left" rowspan="1" colspan="1">−2.14</td>
<td align="left" rowspan="1" colspan="1">−2.99</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10374333</td>
<td align="left" rowspan="1" colspan="1">NM_001025597</td>
<td align="left" rowspan="1" colspan="1">Ikzf1</td>
<td align="left" rowspan="1" colspan="1">Ikaros DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">5.19E-05</td>
<td align="left" rowspan="1" colspan="1">−1.31</td>
<td align="left" rowspan="1" colspan="1">−1.77</td>
<td align="left" rowspan="1" colspan="1">−1.99</td>
<td align="left" rowspan="1" colspan="1">−2.44</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10560964</td>
<td align="left" rowspan="1" colspan="1">NM_011138</td>
<td align="left" rowspan="1" colspan="1">Pou2f2</td>
<td align="left" rowspan="1" colspan="1">Oct-2 DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">6.20E-03</td>
<td align="left" rowspan="1" colspan="1">−1.24</td>
<td align="left" rowspan="1" colspan="1">−1.30</td>
<td align="left" rowspan="1" colspan="1">−1.84</td>
<td align="left" rowspan="1" colspan="1">−2.56</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10517090</td>
<td align="left" rowspan="1" colspan="1">NM_001080819</td>
<td align="left" rowspan="1" colspan="1">Arid1a</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">3.60E-03</td>
<td align="left" rowspan="1" colspan="1">−1.05</td>
<td align="left" rowspan="1" colspan="1">−1.25</td>
<td align="left" rowspan="1" colspan="1">−1.21</td>
<td align="left" rowspan="1" colspan="1">−2.16</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10371662</td>
<td align="left" rowspan="1" colspan="1">NM_011461</td>
<td align="left" rowspan="1" colspan="1">Sp1c</td>
<td align="left" rowspan="1" colspan="1">Pu.1 Dna binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.04</td>
<td align="left" rowspan="1" colspan="1">−1.05</td>
<td align="left" rowspan="1" colspan="1">1.13</td>
<td align="left" rowspan="1" colspan="1">1.15</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10585276</td>
<td align="left" rowspan="1" colspan="1">NM_011136</td>
<td align="left" rowspan="1" colspan="1">Pou2af1</td>
<td align="left" rowspan="1" colspan="1">OBF/OcaB DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.10</td>
<td align="left" rowspan="1" colspan="1">−1.22</td>
<td align="left" rowspan="1" colspan="1">−1.22</td>
<td align="left" rowspan="1" colspan="1">−1.53</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10359770</td>
<td align="left" rowspan="1" colspan="1">NM_011137</td>
<td align="left" rowspan="1" colspan="1">Pou2f1</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.10</td>
<td align="left" rowspan="1" colspan="1">−1.22</td>
<td align="left" rowspan="1" colspan="1">−1.22</td>
<td align="left" rowspan="1" colspan="1">−1.53</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10370837</td>
<td align="left" rowspan="1" colspan="1">NM_011548</td>
<td align="left" rowspan="1" colspan="1">E2a</td>
<td align="left" rowspan="1" colspan="1">helix-loop-helix DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.18</td>
<td align="left" rowspan="1" colspan="1">−1.15</td>
<td align="left" rowspan="1" colspan="1">−1.37</td>
<td align="left" rowspan="1" colspan="1">−1.68</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10399691</td>
<td align="left" rowspan="1" colspan="1">NM_010496</td>
<td align="left" rowspan="1" colspan="1">Id2</td>
<td align="left" rowspan="1" colspan="1">inhibitor hlh DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.39</td>
<td align="left" rowspan="1" colspan="1">−2.78</td>
<td align="left" rowspan="1" colspan="1">−3.18</td>
<td align="left" rowspan="1" colspan="1">−4.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10509163</td>
<td align="left" rowspan="1" colspan="1">NM_008321</td>
<td align="left" rowspan="1" colspan="1">Id3</td>
<td align="left" rowspan="1" colspan="1">inhibitor hlh DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">1.46</td>
<td align="left" rowspan="1" colspan="1">1.39</td>
<td align="left" rowspan="1" colspan="1">1.29</td>
<td align="left" rowspan="1" colspan="1">−1.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10576034</td>
<td align="left" rowspan="1" colspan="1">NM_008320</td>
<td align="left" rowspan="1" colspan="1">Irf8</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">1.36</td>
<td align="left" rowspan="1" colspan="1">1.07</td>
<td align="left" rowspan="1" colspan="1">−1.07</td>
<td align="left" rowspan="1" colspan="1">−1.63</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10512669</td>
<td align="left" rowspan="1" colspan="1">NM_008782</td>
<td align="left" rowspan="1" colspan="1">Pax5</td>
<td align="left" rowspan="1" colspan="1">DNA binding factor</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">1.04</td>
<td align="left" rowspan="1" colspan="1">−1.22</td>
<td align="left" rowspan="1" colspan="1">−1.32</td>
<td align="left" rowspan="1" colspan="1">−1.92</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10485372</td>
<td align="left" rowspan="1" colspan="1">NM_009019</td>
<td align="left" rowspan="1" colspan="1">Rag1</td>
<td align="left" rowspan="1" colspan="1">V(D)J recombination</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.45</td>
<td align="left" rowspan="1" colspan="1">−1.63</td>
<td align="left" rowspan="1" colspan="1">−2.03</td>
<td align="left" rowspan="1" colspan="1">−1.50</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">10485370</td>
<td align="left" rowspan="1" colspan="1">NM_009020</td>
<td align="left" rowspan="1" colspan="1">Rag2</td>
<td align="left" rowspan="1" colspan="1">V(D)J recombination</td>
<td align="left" rowspan="1" colspan="1">n.s.</td>
<td align="left" rowspan="1" colspan="1">−1.63</td>
<td align="left" rowspan="1" colspan="1">−1.21</td>
<td align="left" rowspan="1" colspan="1">−1.76</td>
<td align="left" rowspan="1" colspan="1">−1.72</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label>a</label><p><italic>p</italic> value in ANOVA analysis.</p></fn><fn id="nt102"><label>b</label><p>Fold change times up-regulated or down-regulated (−) when compared with WT (V<sub>H</sub>81X Tg <italic>Rag1</italic><sup>−/−</sup>) pre-B cells.</p></fn><fn id="nt103"><label/><p>Groups are Rag1 KO <italic>Rag1</italic><sup>−/−</sup> pro-B cells; Btk KO <italic>Btk</italic><sup>−/−</sup> V<sub>H</sub>81X Tg <italic>Rag1</italic><sup>−/−</sup> pre-B cells; Slp65 KO <italic>Slp65</italic><sup>−/−</sup> V<sub>H</sub>81X Tg <italic>Rag1</italic><sup>−/−</sup> pre-B cells; BtkSlp65 KO <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> V<sub>H</sub>81X Tg <italic>Rag1<sup>−/−</sup></italic> pre-B cells.</p></fn><fn id="nt104"><label>c</label><p>n.s., <italic>p</italic>&gt;0.01.</p></fn></table-wrap-foot></table-wrap>
<p>Next, we used quantitative RT-PCR to confirm the observed differential expression of several TFs. Expression levels of these genes were indeed significantly reduced in a pre-BCR signaling-dependent manner, especially for Aiolos, Ikaros, and Irf4, with residual expression levels in <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pre-B cells that were ∼1%, ∼20%, and ∼9% of those observed in WT VH81x <italic>Rag1</italic><sup>−/−</sup> mice, respectively (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1C</xref>). In addition, we found moderate effects on <italic>Obf1</italic> (Oca-B) and <italic>E2a</italic> with residual expression levels of ∼28% and ∼44%, respectively. In chromatin immunoprecipitation (ChIP) assays, we observed in pre-B cells substantial binding of E2a protein to the intronic and 3′ κ enhancer regions and to the three V<sub>κ</sub> regions analyzed. Under conditions of reduced pre-BCR signaling activity, E2a binding to the enhancers was essentially maintained (3′Eκ) or reduced (iEκ), but E2a binding to the V<sub>κ</sub> regions was lost (<xref ref-type="supplementary-material" rid="pbio.1001791.s012">Table S3</xref>). Consistent with the significant reduction of Ikaros expression in <italic>Slp65</italic><sup>−/−</sup> pre-B cells, Ikaros binding to both κ enhancers and V<sub>κ</sub> regions was undetectable in these cells (<xref ref-type="supplementary-material" rid="pbio.1001791.s012">Table S3</xref>).</p>
<p>Taken together, from these findings we conclude that the five groups of pro-B/pre-B cells, representing a gradient of progressively diminished pre-BCR signaling, show in parallel a gradient of diminished modulation of many genes that signify pre-B cell differentiation, including key genes implicated in <italic>Igκ</italic> gene recombination.</p>
</sec><sec id="s2b">
<title>Progressively Diminished V<sub>κ</sub> and J<sub>κ</sub> GLTs in <italic>Btk</italic><sup>−/−</sup>, <italic>Slp65</italic><sup>−/−</sup>, and <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> Pre-B Cells</title>
<p>In these expression profiling studies, we only detected limited differences in germline transcription (GLT) over unrearranged J<sub>κ</sub> and V<sub>κ</sub> gene segments, which is thought to reflect locus accessibility <xref ref-type="bibr" rid="pbio.1001791-Yancopoulos1">[12]</xref>. However, we previously showed by serial-dilution RT-PCR that the levels of κ<sup>0</sup> 0.8 and κ<sup>0</sup> 1.1 germline transcripts, which are initiated in different regions 5′of J<sub>κ</sub> and spliced to the C<sub>κ</sub> region <xref ref-type="bibr" rid="pbio.1001791-Engel1">[49]</xref>, are apparently normal in <italic>Btk</italic><sup>−/−</sup> pre-B cells, modestly reduced in <italic>Slp65</italic><sup>−/−</sup> pre-B cells, and severely reduced in <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>. We could confirm these findings for κ<sup>0</sup> GLT by quantitative RT-PCR assays on FACS-purified B220<sup>+</sup>CD19<sup>+</sup> pro-B/pre-B cell fractions (<xref ref-type="fig" rid="pbio-1001791-g002">Figure 2A</xref>). In agreement with our reported findings <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>, we also found that <italic>Btk</italic><sup>−/−</sup>and <italic>Slp65</italic><sup>−/−</sup> pre-B cells have defective λ<sup>0</sup> transcription, which is initiated 5′ of the J<sub>λ</sub> segments (<xref ref-type="fig" rid="pbio-1001791-g002">Figure 2B</xref>) <xref ref-type="bibr" rid="pbio.1001791-Engel1">[49]</xref>.</p>
<fig id="pbio-1001791-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g002</object-id><label>Figure 2</label><caption>
<title>Reduction of Btk/Slp65-mediated pre-BCR signaling is associated with progressive loss of Igκ GLT.</title>
<p>Quantitative RT-PCR analysis for κ<sup>0</sup> (A), λ<sup>0</sup> (B), and V<sub>κ</sub> GLT (C) of FACS-sorted B220<sup>+</sup>CD19<sup>+</sup> pre-B/pro-B cell fractions from the indicated mice on a VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> background. Expression levels were normalized to those of <italic>Gapdh</italic>, whereby the values in WT pre-B cells were set to one. Bars represent mean values and error bars denote standard deviations for four independent mice per group.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g002" position="float" xlink:type="simple"/></fig>
<p>GLT across the V<sub>κ</sub> region showed a similar pattern of sensitivity to pre-BCR signaling: decreased transcription of six individual V<sub>κ</sub> regions tested (V<sub>κ</sub>3–7, V<sub>κ</sub>8–24, V<sub>κ</sub>4–55, V<sub>κ</sub>10–96, V<sub>κ</sub>1–35, and V<sub>κ</sub>2–137) correlated with decreased pre-BCR signaling activity (<xref ref-type="fig" rid="pbio-1001791-g002">Figure 2C</xref>) in the pre-B cells of the four groups of mice. GLT over unrearranged V<sub>λ</sub>1 and V<sub>λ</sub>2 segments was strongly reduced in the absence of Btk or Slp65, as detected by the expression arrays (<xref ref-type="table" rid="pbio-1001791-t001">Table 1</xref>).</p>
<p>These observations indicate that <italic>Igκ</italic> locus accessibility, a hallmark of recombination-competent antigen receptor loci, is progressively reduced under conditions of diminishing pre-BCR signaling.</p>
</sec><sec id="s2c">
<title>Pre-BCR Signaling Induces Modulation of Long-Range Chromatin Interactions at the <italic>Igκ</italic> Locus</title>
<p>Accessibility of antigen receptor loci for V(D)J recombination is thought to be initiated by enhancers, in part through long-range chromatin interactions with promoters of noncoding transcription, resulting in the activation of germline transcription <xref ref-type="bibr" rid="pbio.1001791-Cobb1">[8]</xref>. Because pre-BCR signaling affects the expression of GLT and various nuclear proteins that mediate long-range chromatin interactions and bind the κ enhancers, it is conceivable that pre-BCR signaling induces changes in the enhancer-mediated higher order chromatin structure of the <italic>Igκ</italic> locus that facilitates V<sub>κ</sub> gene accessibility.</p>
<p>We therefore performed 3C-Seq analyses on FACS-purified B220<sup>+</sup>CD19<sup>+</sup> fractions from the same five groups of mice (WT, <italic>Btk</italic><sup>−/−</sup>, <italic>Slp65</italic><sup>−/−</sup>, and <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> pre-B cells, as well as <italic>Rag1</italic><sup>−/−</sup> pro-B cells). Erythroid progenitors were analyzed in parallel as a nonlymphoid control, in which the <italic>Igκ</italic> locus was not contracted. Genome-wide chromatin interactions were measured for three regulatory elements involved in the control of <italic>Igκ</italic> locus accessibility and recombination: the iEκ and 3′Eκ enhancers <xref ref-type="bibr" rid="pbio.1001791-Gorman1">[50]</xref>–<xref ref-type="bibr" rid="pbio.1001791-Inlay2">[52]</xref> and the Sis element <xref ref-type="bibr" rid="pbio.1001791-Liu1">[20]</xref>, which contain binding sites for Ikaros/Aiolos, E2a, and Irf4 <xref ref-type="bibr" rid="pbio.1001791-Muljo1">[16]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Lu1">[17]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Liu1">[20]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Lazorchak1">[38]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Greenbaum1">[53]</xref>.</p>
<p>In WT pre-B cells, all three regulatory elements showed extensive long-range chromatin interactions within the V<sub>κ</sub> region and substantially less interactions with regions up- or downstream of the ∼3.2 Mb <italic>Igκ</italic> domain (<xref ref-type="fig" rid="pbio-1001791-g003">Figure 3A</xref>; see <xref ref-type="supplementary-material" rid="pbio.1001791.s002">Figure S2</xref>, <xref ref-type="supplementary-material" rid="pbio.1001791.s003">Figure S3</xref>, and <xref ref-type="supplementary-material" rid="pbio.1001791.s004">Figure S4</xref> for line graphs), confirming previous observations <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>. Under conditions of reduced pre-BCR signaling activity, the three <italic>Igκ</italic> regulatory elements still showed strong interactions with the V<sub>κ</sub> region. Surprisingly, even in the complete absence of pre-BCR signaling in <italic>Rag1</italic><sup>−/−</sup> pro-B cells, long-range interactions were still observed at frequencies well above those seen in nonlymphoid cells, suggesting that a contracted <italic>Igκ</italic> locus topology is not strictly dependent on pre-BCR signaling (<xref ref-type="fig" rid="pbio-1001791-g003">Figure 3A</xref>, <xref ref-type="supplementary-material" rid="pbio.1001791.s002">Figure S2</xref>, <xref ref-type="supplementary-material" rid="pbio.1001791.s003">Figure S3</xref>, and <xref ref-type="supplementary-material" rid="pbio.1001791.s004">Figure S4</xref>). Next, we used 3D DNA FISH analyses using BAC probes hybridizing to the distal V<sub>κ</sub> and C<sub>κ</sub>/enhancer regions to confirm that <italic>Igκ</italic> locus contraction was similar in <italic>Rag-1</italic><sup>−/−</sup> pro-B cells and VH81x transgenic <italic>Rag-1</italic><sup>−/−</sup> pre-B cells (both showing a contracted topology, compared with noncontracted pre–pro-B cells deficient for the TF E2a; <xref ref-type="fig" rid="pbio-1001791-g003">Figure 3B</xref>).</p>
<fig id="pbio-1001791-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g003</object-id><label>Figure 3</label><caption>
<title>3C-Seq analysis of long-range chromatin interactions within the Igκ locus and flanking regions.</title>
<p>(A) Overview of long-range interactions revealed by 3C-Seq experiments performed on the indicated cell fractions, representing a gradient of pre-BCR signaling, whereby the iEκ element (top), the 3′Eκ element (center), or the Sis element (bottom) was used as a viewpoint. Shown are the relative interaction frequencies (average of two replicate experiments) for the indicated genomic locations. The ∼8.4 Mb region containing the Ig<italic>κ</italic> locus (yellow shading) and flanking regions (cyan shading) is shown and genes and genomic coordinates are given (bottom). The locations of the two BAC probes used for 3D DNA-FISH are indicated by a green (distal V<sub>κ</sub> probe) and red (proximal C<sub>κ</sub>/enhancer probe) rectangle (<italic>bottom</italic>). Pre-B cell fractions were FACS-purified from the indicated mice on a VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> background (see <xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref> for gating strategy). Erythroid progenitor cells were used as a nonlymphoid control. (B) 3D DNA-FISH analysis comparing locus contraction in cultured bone-marrow–derived <italic>E2a</italic><sup>−/−</sup> pre-pro-B, <italic>Rag1</italic><sup>−/−</sup> pro-B, and VH81x <italic>Rag1</italic><sup>−/−</sup> pre-B cells (see <xref ref-type="supplementary-material" rid="pbio.1001791.s006">Figure S6</xref> for phenotype of IL-7 cultured B-lineage cells). Locations of the BAC probes used are indicated at the bottom of panel A. Representative images for all three cell types are shown on the left, quantifications (&gt;100 nuclei counted per cell type) on the right. The red lines indicate the median distance between the two probes. Statistical significance was determined using a Mann–Whitney U test (***<italic>p</italic>&lt;0.001; n.s., not significant, <italic>p</italic>≥0.05).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g003" position="float" xlink:type="simple"/></fig>
<p>Nevertheless, we did observe that pre-BCR signaling induced clear differences in interaction frequencies. Whereas an increase in pre-BCR signaling was associated with a decrease in the interaction frequencies between the two κ enhancers and regions flanking the <italic>Igκ</italic> locus (as also revealed by more detailed images of selected regions upstream and downstream of the <italic>Igκ</italic> domain; see <xref ref-type="supplementary-material" rid="pbio.1001791.s005">Figure S5</xref>), the overall interaction frequency within the <italic>Igκ</italic> domain appeared unchanged (<xref ref-type="supplementary-material" rid="pbio.1001791.s003">Figure S3</xref>, <xref ref-type="supplementary-material" rid="pbio.1001791.s004">Figure S4</xref>, and <xref ref-type="supplementary-material" rid="pbio.1001791.s005">Figure S5</xref>). Remarkably, interactions with the Sis element showed quite an opposite pattern: pre-BCR signaling correlated with increased overall interactions within the <italic>Igκ</italic> domain and did not substantially affect interaction frequencies in the <italic>Igκ</italic> flanking regions (<xref ref-type="supplementary-material" rid="pbio.1001791.s002">Figure S2</xref> and <xref ref-type="supplementary-material" rid="pbio.1001791.s005">Figure S5</xref>).</p>
<p>Taken together, these analyses show that (i) the <italic>Igκ</italic> locus is already contracted at the pro-B cell stage and that (ii) pre-BCR signaling induces changes in long-range chromatin interactions, both within the <italic>Igκ</italic> locus and in the flanking regions.</p>
</sec><sec id="s2d">
<title>Pre-BCR Signaling Enhances Interactions of 3′Eκ and Sis, But Not iEκ, with V<sub>κ</sub><sup>+</sup> Fragments</title>
<p>The differential effects of pre-BCR signaling on long-range chromatin interactions of the iEκ, 3′Eκ, and Sis elements clearly emerged in a quantitative analysis of the 3C-seq datasets (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4A</xref>; see <xref ref-type="sec" rid="s4">Materials and Methods</xref> for a detailed description of the quantification methods used). When pre-BCR signaling was absent (<italic>Rag1</italic><sup>−/−</sup> pro-B cells) or very low (<italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells), the average interaction frequencies were similar within the ∼3.2 Mb V<sub>κ</sub> region and the ∼3.2 Mb downstream flanking region, for all three regulatory elements. Interaction frequencies with the upstream flanking region were lower, consistent with the larger chromosomal distance to the three viewpoints. The presence of increasing levels of Btk/Slp65-mediated pre-BCR signaling was associated with reduced interaction of iEκ and 3′Eκ with the <italic>Igκ</italic> flanking regions and with increased interaction of the Sis element and (to a lesser extent) 3′Eκ with the V<sub>κ</sub> region (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4A</xref>). As a result, for all three regulatory elements pre-BCR signaling resulted in a preference for interaction with fragments inside the V<sub>κ</sub> region over fragments outside the V<sub>κ</sub> region (<xref ref-type="supplementary-material" rid="pbio.1001791.s007">Figure S7</xref>).</p>
<fig id="pbio-1001791-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g004</object-id><label>Figure 4</label><caption>
<title>Modulation of long-range chromatin interactions within the Igκ locus by pre-BCR signaling.</title>
<p>Quantitative analysis of 3C-Seq datasets using the three indicated κ regulatory elements as viewpoints. (A) Average long-range chromatin interaction frequencies (from two replicate 3C-seq experiments) with upstream (∼2.0 Mb), V<sub>κ</sub> (∼3.2 Mb), and downstream (∼3.2 Mb) regions, as defined in <xref ref-type="fig" rid="pbio-1001791-g003">Figure 3A</xref>, for the five B-cell precursor fractions representing a pre-BCR signaling gradient. Average interaction frequencies per region were calculated as the average number of 3C-Seq reads per restriction fragment within that region. See <xref ref-type="sec" rid="s4">Materials and Methods</xref> section for more details. (B) Average interaction frequencies within the V<sub>κ</sub> region were determined for fragments that do not (−) contain a functional V<sub>κ</sub> gene and for those that do contain a functional V<sub>κ</sub> gene (+). (C) Correlation plots of average interaction frequencies of the two enhancer elements with the 101 functional V<sub>κ</sub> genes for WT pre-B cells (left) versus <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells (right). On the log scale, frequencies &lt;1 were set to 10<sup>0</sup>. Statistical significance was determined using a Mann–Whitney U test (*<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; n.s., not significant, <italic>p</italic>≥0.05).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g004" position="float" xlink:type="simple"/></fig>
<p>We next focused our analysis on the V<sub>κ</sub> region and compared fragments that harbor a functional V<sub>κ</sub> gene (V<sub>κ</sub><sup>+</sup> fragment) and those that do not (V<sub>κ</sub><sup>−</sup> fragment). When pre-BCR signaling was absent (<italic>Rag1</italic><sup>−/−</sup> pro-B cells) or very low (<italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells), the average interaction frequencies of the Sis or iEκ elements with V<sub>κ</sub><sup>+</sup> fragments were higher than with V<sub>κ</sub><sup>−</sup> fragments. The average interaction frequencies of 3′Eκ with V<sub>κ</sub><sup>+</sup> and V<sub>κ</sub><sup>−</sup> fragments, however, were similar (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4B</xref>). Upon pre-BCR signaling, the Sis element showed an increase in interaction frequencies with both V<sub>κ</sub><sup>+</sup> and V<sub>κ</sub><sup>−</sup> fragments, with nevertheless an interaction preference for V<sub>κ</sub><sup>+</sup> fragments. In contrast, interaction frequencies between the iEκ element and V<sub>κ</sub><sup>+</sup> or V<sub>κ</sub><sup>−</sup> fragments were not modulated by pre-BCR signaling at all (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4B</xref>). The 3′Eκ element exhibited yet another profile: pre-BCR signaling induced increased interaction frequencies specifically with V<sub>κ</sub><sup>+</sup> fragments, while interactions with V<sub>κ</sub><sup>−</sup> fragments were not notably modulated by pre-BCR signaling (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4B</xref>). When we separately analyzed nonfunctional pseudo-V<sub>κ</sub> genes, we found for the Sis and 3′Eκ elements that the interaction patterns with functional and nonfunctional V<sub>κ</sub> genes were similar (<xref ref-type="supplementary-material" rid="pbio.1001791.s008">Figure S8</xref>). In contrast, the iEκ enhancer did show an overall increased interaction frequency with V<sub>κ</sub> functional genes, compared with nonfunctional V<sub>κ</sub> genes, a phenomenon which was again independent from pre-BCR signaling (<xref ref-type="supplementary-material" rid="pbio.1001791.s008">Figure S8</xref>).</p>
<p>The finding that interactions of V<sub>κ</sub> genes with the intronic enhancer are already robust in pro-B cells, while those with the 3′κ enhancer are dependent on pre-BCR signaling, suggested that for individual V<sub>κ</sub> genes pre-BCR signaling may result in more similar interaction frequencies with the two enhancers. To investigate this, we examined for all individual V<sub>κ</sub> genes the correlation between their 3C-seq interaction frequencies with the iEκ and 3′κ elements and found that these were highly correlated in WT pre-B cells (R<sup>2</sup> = 0.68; <xref ref-type="fig" rid="pbio-1001791-g004">Figure 4C</xref>). Correlation was severely reduced when pre-BCR signaling was low in <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells (R<sup>2</sup> = 0.26; <xref ref-type="fig" rid="pbio-1001791-g004">Figure 4C</xref>). Similar pre-BCR signaling-dependent correlations were observed between V<sub>κ</sub>-interactions with the Sis element and those with the two enhancers (<xref ref-type="supplementary-material" rid="pbio.1001791.s009">Figure S9</xref>). As the Sis element particularly suppresses recombination of the proximal V<sub>κ</sub>3 family, we investigated interaction correlations specifically for this V<sub>κ</sub> family. Similar to our findings for all V<sub>κ</sub> genes, a subanalysis showed strong correlations for the interactions of V<sub>κ</sub>3 family genes with iEκ, 3′κ, and Sis in WT pre-B cells, which were diminished when pre-BCR signaling was low, except for iEκ–Sis correlations, which were pre-BCR signaling-independent (<xref ref-type="supplementary-material" rid="pbio.1001791.s009">Figure S9</xref>).</p>
<p>In summary, we conclude that pre-BCR signaling induces a redistribution of long-range interactions of the iEκ, 3′Eκ, and Sis elements, thereby restricting interactions towards the V<sub>κ</sub> gene region. Moreover, upon pre-BCR signaling the long-range interactions mediated by 3′Eκ and Sis—but not those mediated by iEκ—become enriched for fragments harboring a V<sub>κ</sub> gene, demonstrating increased proximity of 3′Eκ and Sis to V<sub>κ</sub> genes. Finally, for individual V<sub>κ</sub> genes, the interactions with iEκ, 3′Eκ, and Sis become highly correlated upon pre-BCR signaling, indicating that pre-BCR signals result in regulatory coordination between these three elements that govern <italic>Igκ</italic> locus recombination. In contrast, interactions between genes of the proximal V<sub>κ</sub>3 family, Sis and iEκ—but not 3′κ—appear to be coordinated already in the absence of pre-BCR signaling.</p>
</sec><sec id="s2e">
<title>Long-Range Chromatin Interactions of κ Regulatory Elements Correlate with V<sub>κ</sub> Usage</title>
<p>Next, we investigated the effects of pre-BCR signaling on the interaction frequencies of individual functional V<sub>κ</sub> genes with the three κ regulatory elements (<xref ref-type="fig" rid="pbio-1001791-g005">Figure 5A,B</xref>). The 3C-seq patterns of the majority (∼91%) of the 101 individual V<sub>κ</sub><sup>+</sup> fragments showed evidence for interaction with one or more of the κ regulatory elements (&gt;25 average counts). When comparing <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> with WT pre-B cells, we observed that for a large proportion (∼38–52%) of V<sub>κ</sub><sup>+</sup> fragments, interaction frequencies increased upon pre-BCR signaling (<xref ref-type="fig" rid="pbio-1001791-g005">Figure 5B</xref>). Smaller proportions of V<sub>κ</sub><sup>+</sup> fragments showed a decrease (∼12–29%) or were not significantly affected by pre-BCR signaling (∼17–25% with &lt;1.5-fold change). The observed increase or decrease was not related to proximal or distal location of the V<sub>κ</sub> genes, nor to their sense or antisense orientation (not shown). Distributions of the three different classes of V<sub>κ</sub><sup>+</sup> fragments showed substantial differences between the κ regulatory elements. For the Sis and 3′Eκ elements, more V<sub>κ</sub><sup>+</sup> fragments showed increased than decreased interactions (<xref ref-type="fig" rid="pbio-1001791-g005">Figure 5B</xref>), in agreement with the signaling-dependent increase in average interaction frequencies of all V<sub>κ</sub><sup>+</sup> fragments (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4B</xref>). In contrast, for the iEκ viewpoint, V<sub>κ</sub><sup>+</sup> fragments showing increased and decreased interactions were more equal in number, consistent with the limited effects of pre-BCR signaling on overall iEκ interaction frequencies of all V<sub>κ</sub><sup>+</sup> fragments (<xref ref-type="fig" rid="pbio-1001791-g004">Figure 4B</xref>).</p>
<fig id="pbio-1001791-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g005</object-id><label>Figure 5</label><caption>
<title>Long-range chromatin interactions of κ regulatory elements correlate with V<sub>κ</sub> gene usage.</title>
<p>(A) Selected examples of genomic regions containing V<sub>κ</sub><sup>+</sup> fragments, showing increased (V<sub>κ</sub>4–57, V<sub>κ</sub>6–25, V<sub>κ</sub>8–24, V<sub>κ</sub>4–79), stable (V<sub>κ</sub>8–23–1, V<sub>κ</sub>4–78, V<sub>κ</sub>13–84), or decreased (V<sub>κ</sub>3–9, V<sub>κ</sub>14–111) 3C-seq interaction frequencies with 3′Eκ or iEκ upon pre-BCR signaling. Averaged 3C-seq signals are plotted as a line graph, with the individual data points representing the center of the BglII restriction fragments. Yellow shading marks the BglII fragment on which the V<sub>κ</sub> gene(s) is located. V<sub>κ</sub> gene(s) are indicated (top) and chromosomal coordinates and scale bars (10 kb) are plotted (bottom). (B) Classification of V<sub>κ</sub><sup>+</sup> fragments, based on the effect of pre-BCR signaling on their interactions with the three κ regulatory elements indicated. Increase and decrease were defined as &gt;1.5-fold change of interaction frequencies detected in WT pre-B cells versus <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells. (C) Correlation of average interaction frequencies (for the three κ regulatory elements indicated) with four V<sub>κ</sub> usage categories ranging from low (&lt;0.1%) to high usage (&gt;0.5%, listed in the table on the right). Diamonds represent average interaction frequencies for <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells (yellow) and WT pre-B cells (grey). The dotted line in each graph depicts the average interaction frequency with fragments that do not contain a functional V<sub>κ</sub> (V<sub>κ</sub><sup>−</sup>). Primary V<sub>κ</sub> gene usage data were taken from <xref ref-type="bibr" rid="pbio.1001791-AokiOta1">[54]</xref>.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g005" position="float" xlink:type="simple"/></fig>
<p>Although antigen receptor recombination is in principle regarded as a random process, a significant skewing of the primary Igκ repertoire of C57BL/6 mice was recently reported: one third of the V<sub>κ</sub> genes was shown to account for &gt;85% of the V<sub>κ</sub> segments used by B cells <xref ref-type="bibr" rid="pbio.1001791-AokiOta1">[54]</xref>. To assess whether a correlation exists between usage of V<sub>κ</sub> genes and their interaction frequencies with κ regulatory elements, we divided the V<sub>κ</sub> genes into four usage categories (&lt;0.1%, 0.1–0.3%, 0.3–0.5%, and &gt;0.5%) and calculated their average 3C-Seq interaction frequencies with Sis, iEκ, and 3′κ (<xref ref-type="fig" rid="pbio-1001791-g005">Figure 5C</xref>). In WT pre-B cells, V<sub>κ</sub> usage showed a strong positive correlation with 3C-Seq interaction frequencies for all three regulatory elements (R<sup>2</sup> = ∼0.7–0.9; <xref ref-type="fig" rid="pbio-1001791-g005">Figure 5C</xref>). These correlations were pre-BCR signaling-dependent, since in <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells, they were reduced (for iEκ; R<sup>2</sup> = 0.33) or absent (for Sis and 3′κ; R<sup>2</sup>&lt;0.10 and R<sup>2</sup>&lt;0.16, respectively) (<xref ref-type="fig" rid="pbio-1001791-g005">Figure 5C</xref>).</p>
<p>Collectively, our results indicate that specifically the most frequently used V<sub>κ</sub> genes are the main interaction targets of κ regulatory elements, whereby pre-BCR signaling completely underlies this specificity for the Sis and 3′Eκ elements, and to a lesser extent for iEκ.</p>
</sec><sec id="s2f">
<title>Long-Range Interactions with κ Regulatory Elements Correlate with the Presence of Ctcf, Ikaros, E2a, and H3K4 Hypermethylation</title>
<p>Next, we investigated whether long-range interactions between κ regulatory elements and the V<sub>κ</sub> region correlated with the presence of the TFs Ctcf <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>, Ikaros <xref ref-type="bibr" rid="pbio.1001791-FerreirosVidal1">[55]</xref>, and E2a <xref ref-type="bibr" rid="pbio.1001791-Lin2">[56]</xref>, which have been implicated in <italic>Igκ</italic> locus recombination <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Inlay1">[37]</xref>,<xref ref-type="bibr" rid="pbio.1001791-FerreirosVidal1">[55]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Sakamoto1">[57]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Heizmann1">[58]</xref>. Notably, Ikaros and E2a both strongly bind all three κ regulatory elements, while the Sis element is also occupied by Ctcf (<xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>; unpublished data).</p>
<p>Remarkably, we found similar striking correlations between the presence of <italic>in vivo</italic> binding sites for each of these TFs (as determined by ChIP experiments; see <xref ref-type="sec" rid="s4">Materials and Methods</xref> for the relevant references) and long-range chromatin interactions with the κ regulatory elements (<xref ref-type="fig" rid="pbio-1001791-g006">Figure 6A–C</xref>), even though Ctcf sites are mostly located in between V<sub>κ</sub> genes <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref> and Ikaros/E2a sites were frequently found close to V<sub>κ</sub> gene promoter regions (<xref ref-type="bibr" rid="pbio.1001791-Bossen1">[2]</xref>; <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7A</xref>). Even when pre-BCR signaling was absent (<italic>Rag1</italic><sup>−/−</sup> pro B cells) or very low (<italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells), the average interaction frequencies of the κ regulatory elements with fragments containing Ctcf, Ikaros, or E2a bindings sites were higher than those without binding sites. Irrespective of the presence or absence of bindings sites for these TFs, we found that upon pre-BCR signaling interaction frequencies with the Sis element increased and those with the iEκ did not change. In contrast, for the 3′Eκ we found that pre-BCR signaling specifically increased interaction frequencies with fragments occupied by Ctcf, Ikaros, or E2a.</p>
<fig id="pbio-1001791-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g006</object-id><label>Figure 6</label><caption>
<title>Long-range chromatin interactions of κ regulatory elements correlate with TF binding and histone modifications.</title>
<p>(A-D) For fragments within the V<sub>κ</sub> region, average 3C-seq interaction frequencies were calculated for fragments that did (+) or did not (−) contain binding sites for TFs or H3K4 histone modifications (as determined by previous ChIP-Seq studies; see <xref ref-type="sec" rid="s4">Materials and Methods</xref> for references). Data for the three viewpoint and the five B-cell precursor fractions representing a pre-BCR signaling gradient are shown for Ctcf (A), Ikaros (B), E2a (C), and H3K4 di- and tri-methylation (Me2/3). Statistical significance was determined using a Mann–Whitney U test (*<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; n.s., not significant, <italic>p</italic>≥0.05).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g006" position="float" xlink:type="simple"/></fig><fig id="pbio-1001791-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pbio.1001791.g007</object-id><label>Figure 7</label><caption>
<title>Proximity of V<sub>κ</sub> genes to E2a binding sites correlates with frequencies of long-range interactions.</title>
<p>(A) Schematic representation of the <italic>Igκ</italic> locus, showing the location of all functional V<sub>κ</sub> (grey, top), J<sub>κ</sub> and C<sub>κ</sub> gene segments, and the κ regulatory elements Sis, iEκ, and 3′Eκ. MAR, matrix attachment region. V<sub>κ</sub> genes within close proximity (as defined by colocalization on the same 3C-Seq restriction fragment) to the indicated TFs or H3K4 hypermethylation (as detected by previous ChIP-seq studies; see <xref ref-type="sec" rid="s4">Materials and Methods</xref> for references) are shown. At the bottom, highly used (&gt;1.0% used) V<sub>κ</sub> gene segments are depicted (orange), which cluster within two large high-usage domains (yellow shading). Primary V<sub>κ</sub> gene usage data was taken from <xref ref-type="bibr" rid="pbio.1001791-AokiOta1">[54]</xref>. (B) Average usage of V<sub>κ</sub> genes marked only by an Ikaros binding site or those marked by binding sites of both Ikaros and E2a. (C) Comparison of average interaction frequencies (for the three κ regulatory elements indicated) between V<sub>κ</sub><sup>−</sup> fragments (no V<sub>κ</sub>), V<sub>κ</sub><sup>+</sup> fragments containing an Ikaros binding site only, and V<sub>κ</sub><sup>+</sup> fragments containing both an Ikaros and E2a binding site. Bars represent average frequencies for <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells (yellow) and WT pre-B cells (grey). (D) Classification of V<sub>κ</sub><sup>+</sup> fragments, containing an Ikaros binding site only (top) or containing both an Ikaros and E2a binding site (bottom), based on the effect of pre-BCR signaling on their interactions with the three κ regulatory elements indicated. Increase and decrease were defined as &gt;1.5-fold change of interaction frequencies detected in WT pre-B cells versus <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells. (E) Proposed model of pre-BCR signaling-mediated changes in κ enhancer action. In pro-B cells (left) the enhancers show minimal coordination and their interactions are not yet (fully) focused on the V<sub>κ</sub> genes. Upon pre-BCR signaling and differentiation to pre-B cells (right), TFs bind the locus to coordinate enhancer action and focus their interactions to the V<sub>κ</sub> genes, inducing germline transcription (GLT) and accessibility to the V(D)J recombinase. See <xref ref-type="sec" rid="s3">Discussion</xref> for more details. Statistical significance was determined using a Mann–Whitney U test (*<italic>p</italic>&lt;0.05; **<italic>p</italic>&lt;0.01; ***<italic>p</italic>&lt;0.001; n.s., not significant, <italic>p</italic>≥0.05).</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pbio.1001791.g007" position="float" xlink:type="simple"/></fig>
<p>Finally, we found that the presence of di- or trimethylation of histone 3 lysine 4 (H3K4Me2/3), an epigenetic signature associated with locus accessibility <xref ref-type="bibr" rid="pbio.1001791-Feeney1">[59]</xref> and Rag-binding <xref ref-type="bibr" rid="pbio.1001791-Liu2">[60]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Matthews1">[61]</xref>, also correlated with increased interaction frequencies with κ regulatory elements, revealing a similar pre-BCR signaling dependency as seen for the TFs analyzed (<xref ref-type="fig" rid="pbio-1001791-g006">Figure 6D</xref>).</p>
<p>We conclude that the presence of essential TFs or H3K4Me2/3 in the V<sub>κ</sub> region strongly correlates with the formation of long-range chromatin interactions with the κ regulatory elements, and that for the Sis and 3′Eκ elements this interaction preference is further enhanced by pre-BCR signaling.</p>
</sec><sec id="s2g">
<title>Proximity of V<sub>κ</sub> Genes to E2a Binding Sites Correlates with High V<sub>κ</sub> Usage and Increased Long-Range Chromatin Interactions</title>
<p>Since the long-range interactions with κ regulatory elements correlated with the presence of TFs implicated in <italic>Igκ</italic> recombination, we next asked whether the κ regulatory elements preferentially interacted with V<sub>κ</sub> genes that are in close proximity to binding sites for Ctcf, Ikaros, or E2a.</p>
<p>Strikingly, the majority of functional V<sub>κ</sub> genes (95/101) was found to have an Ikaros binding site in close proximity—that is, located on the same 3C-seq restriction fragment (average length of ∼3 kb, unpublished data) (<xref ref-type="fig" rid="pbio-1001791-g007">Figure 7A</xref>). Proximity of V<sub>κ</sub> genes to an E2a binding site (37%) or H3K4Me2/3 positive region (∼28%) is more selective, while only a small fraction of V<sub>κ</sub> genes are close to Ctcf binding sites (∼12%) (<xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida2">[22]</xref>; <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7A</xref>). All V<sub>κ</sub> genes marked by E2a, Ctcf, H3K4Me2/3, or a combination of these also contain an Ikaros binding site. Frequently used V<sub>κ</sub> genes (&gt;1.0% usage; 33/101 genes) were located in two separate regions, a proximal and a distal region, which also contained virtually all E2a and H2K4Me2/3-marked V<sub>κ</sub> genes (<xref ref-type="fig" rid="pbio-1001791-g007">Figure 7A</xref>).</p>
<p>We found that V<sub>κ</sub> genes marked by both Ikaros and E2a were used substantially more often than those only bound by Ikaros (<xref ref-type="fig" rid="pbio-1001791-g007">Figure 7B</xref>), suggesting that these V<sub>κ</sub> genes are preferentially targeted for V<sub>κ</sub>-to-J<sub>κ</sub> gene rearrangement. Our 3C-seq analyses showed that in WT pre-B cells, interaction frequencies with the three κ regulatory elements were higher for Ikaros/E2a-marked V<sub>κ</sub> genes compared to genes marked by Ikaros binding alone (<xref ref-type="fig" rid="pbio-1001791-g007">Figure 7C</xref>). In fact, V<sub>κ</sub><sup>+</sup> restriction fragments containing an Ikaros binding site but not an E2a binding site showed interaction frequencies similar to V<sub>κ</sub><sup>−</sup> restriction fragments. Under conditions of very low pre-BCR signaling (in <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells), we observed strongly reduced interaction frequencies of V<sub>κ</sub><sup>+</sup> E2a binding restriction fragments with the Sis and 3′Eκ elements. These interaction frequencies were in the same range as those of V<sub>κ</sub><sup>−</sup> fragments or V<sub>κ</sub><sup>+</sup> fragments that harbored an Ikaros site only (<xref ref-type="fig" rid="pbio-1001791-g007">Figure 7C</xref>). Interaction frequencies with the iEκ enhancer, however, were independent of pre-BCR signaling. As shown in <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7D</xref>, for the majority of Ikaros/E2a-marked V<sub>κ</sub><sup>+</sup> fragments (65%), pre-BCR signaling was associated with increased interactions with the Sis and 3′Eκ elements (comparing wild-type and <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells). In these analyses, only ∼13.5% and ∼5.4% of Ikaros/E2a-marked V<sub>κ</sub><sup>+</sup> fragments showed a decreased interaction frequency upon pre-BCR signaling. In contrast, almost equal proportions of Ikaros/E2a-marked V<sub>κ</sub><sup>+</sup> fragments showed increased (∼37%) and decreased (∼30%) interactions with iEκ upon pre-BCR signaling.</p>
<p>Taken together, these data reveal strong positive correlations between the presence of E2a binding sites, V<sub>κ</sub> usage, and long-range chromatin interactions with κ regulatory elements in pre-B cells. Remarkably, for the iEκ element, these correlations are largely independent of Btk/Slp65-mediated pre-BCR signaling, whereas for the 3′Eκ they are completely dependent on signaling.</p>
</sec></sec><sec id="s3">
<title>Discussion</title>
<p>During B-cell development the pre-BCR checkpoint is known to regulate the expression of many genes, part of which control the increase in <italic>Igκ</italic> locus accessibility to the V(D)J recombinase complex. However, it remained unknown how pre-BCR signaling events affect accessibility in terms of <italic>Igκ</italic> locus contraction and topology.</p>
<p>Here we identified numerous genes involved in <italic>IgL</italic> chain recombination, chromatin modification, signaling, and cell survival to be aberrantly expressed in pre-B cells lacking the pre-BCR signaling molecules Btk and/or Slp65. We found that GLT over the Vκ region, reflecting Vκ accessibility, is strongly reduced in these cells. We used 3C-Seq to show that in pro-B cells both the intronic and the 3′ κ enhancers frequently interact with the ∼3.2 Mb Vκ region, as well as with <italic>Igκ</italic> flanking sequences, indicating that the <italic>Igκ</italic> locus is already contracted at the pro-B cell stage. 3C-Seq analyses in wild-type and Btk/Slp65 single- and double-deficient pre-B cells demonstrated that pre-BCR signaling significantly affects <italic>Igκ</italic> locus topology. First, pre-BCR signaling reduces the interactions of the intronic and 3′κ enhancers with <italic>Igκ</italic> flanking regions, effectively focusing enhancer action towards the V<sub>κ</sub> region to facilitate V<sub>κ</sub>-to-J<sub>κ</sub> recombination. Second, pre-BCR signaling strongly increases nuclear proximity of the 3′κ enhancer to V<sub>κ</sub> genes, whereby this increase is more substantial for more frequently used V<sub>κ</sub> genes and for V<sub>κ</sub> genes close to a binding site for the basic helix-loop-helix protein E2a. Third, pre-BCR signaling augments interactions between κ regulatory elements and fragments within the V<sub>κ</sub> region bound by the key B-cell TFs Ikaros and E2a and the architectural protein Ctcf. Fourth, pre-BCR signaling has limited effects on interactions of the intronic κ enhancer with fragments within the <italic>Igκ</italic> locus, as this enhancer already displays interaction specificity for functional V<sub>κ</sub> genes and TF-bound regions in pro-B cells. Fifth, pre-BCR signaling has limited effects on the interactions between the intronic or 3′κ enhancers and fragments that do not contain a V<sub>κ</sub> gene or an Ikaros, E2a, or Ctcf binding site, emphasizing the specificity of pre-BCR signaling-induced changes in <italic>Igκ</italic> locus topology. Sixth, pre-BCR signaling appears to induce mutual regulatory coordination between the three regulatory elements, as their interaction profiles with individual V<sub>κ</sub> genes become highly correlated upon signaling. Finally, pre-BCR signaling increases interactions of the Sis element with DNA fragments in the <italic>Igκ</italic> locus, irrespective of the presence of a V<sub>κ</sub> gene or TF. Collectively, our findings demonstrate that pre-BCR signals relayed through Btk and Slp65 are required to create a chromatin environment that facilitates proper <italic>Igκ</italic> locus recombination. This multistep process is initiated by up-regulation of key TFs like Aiolos, Ikaros, Irf4, and E2a. These proteins are then recruited to or further accumulate at the <italic>Igκ</italic> locus and its regulatory elements, resulting in a specific fine-tuning of enhancer-mediated locus topology that increases locus accessibility to the Rag recombinase proteins.</p>
<p>Importantly, the presence of strong lineage-specific interaction signals between the C<sub>κ</sub>/enhancer region and distal V<sub>κ</sub> genes in pro-B cells indicates that the <italic>Igκ</italic> locus is already contracted at this stage. In contrast to a previous microscopy study indicating that <italic>Igκ</italic> locus contraction did not occur until the small pre-B cell stage <xref ref-type="bibr" rid="pbio.1001791-Roldan1">[36]</xref>, our 3D DNA FISH analysis indeed detected similar nuclear distances between distal V<sub>κ</sub> and the C<sub>κ</sub>/enhancer region in cultured pro-B and pre-B cells. Recently Hi-C was employed to study global early B cell genomic organization whereby substantial interaction frequencies were found between the intronic κ enhancer and the V<sub>κ</sub> region in pro-B cells <xref ref-type="bibr" rid="pbio.1001791-Lin1">[40]</xref>. E2a-deficient pre–pro-B cells, which are not yet fully committed to the B-cell lineage <xref ref-type="bibr" rid="pbio.1001791-Bain1">[62]</xref>, showed very few interactions among the iEκ and the distal part of the V<sub>κ</sub> region <xref ref-type="bibr" rid="pbio.1001791-Lin1">[40]</xref>, resembling the interactions we observed in nonlymphoid cells (<xref ref-type="fig" rid="pbio-1001791-g003">Figure 3A</xref>). Accordingly, 3D-FISH analysis showed that the <italic>Igκ</italic> locus adopted a noncontracted topology in these pre–pro-B cells (<xref ref-type="fig" rid="pbio-1001791-g003">Figure 3B</xref>). These data indicate that <italic>Igκ</italic> locus contraction is already achieved in pro-B cells and depends on the presence of E2a. Supporting this notion, active histone modifications and E2a were already detected at the κ enhancers and V<sub>κ</sub> genes at the pro-B cell stage <xref ref-type="bibr" rid="pbio.1001791-Lin2">[56]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Goldmit1">[63]</xref>, whereby E2a was frequently found at the base of long-range chromatin interactions together with Ctcf and Pu.1, possibly acting as “anchors” to organize genome topology <xref ref-type="bibr" rid="pbio.1001791-Lin1">[40]</xref>. The observed correlation between E2a binding, V<sub>κ</sub> gene usage and iEκ proximity in pro-B cells (<xref ref-type="fig" rid="pbio-1001791-g005">Figure 5C</xref>, <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7C</xref>) further strengthens an early critical role for E2a in regulating <italic>Igκ</italic> locus topology, V<sub>κ</sub> gene accessibility, and recombination.</p>
<p>Our 3C-seq experiments revealed that pre-BCR signaling is not required to induce long-range interactions between the κ regulatory elements and distal parts of the V<sub>κ</sub> locus, indicating that TFs strongly induced by signaling—that is, Aiolos, Ikaros, and Irf4—are not strictly necessary to form a contracted <italic>Igκ</italic> locus. Prime candidates for achieving Igκ locus contraction at the pro-B cell stage are E2a and Ctcf, as they have been implicated in regulating Ig locus topology <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Lin1">[40]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Degner1">[64]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Guo1">[65]</xref> and E2a already marks frequently used V<sub>κ</sub> genes at the pro-B cell stage (<xref ref-type="fig" rid="pbio-1001791-g007">Figure 7</xref>), although we did observe reduced E2a expression and binding to the iEκ enhancer and V<sub>κ</sub> genes when pre-B cell signaling was low (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref> and <xref ref-type="supplementary-material" rid="pbio.1001791.s012">Table S3</xref>), suggesting that pre-BCR signaling is required for high-level E2a occupancy of the V<sub>κ</sub> genes. We previously reported that <italic>Igκ</italic> gene recombination can occur in the absence of Ctcf and that Ctcf mainly functions to limit interactions of the κ enhancers with proximal V<sub>κ</sub> regions and to prevent inappropriate interactions between these strong enhancers and elements outside the Igκ locus <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>. Because at the pro-to-pre–B cell transition Aiolos, Ikaros, and Irf4 are recruited to the <italic>Igκ</italic> locus and histone acetylation and H3K4 methylation increases <xref ref-type="bibr" rid="pbio.1001791-Lu1">[17]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Lazorchak1">[38]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Goldmit1">[63]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Xu2">[66]</xref>, we hypothesize that pre-BCR–induced TFs act upon an E2a/Ctcf-mediated topological scaffold to further refine the long-range chromatin interactions of the κ regulatory elements. Hereby, these TFs mainly act to focus and to coordinate the interactions of the two κ enhancers to the V<sub>κ</sub> gene segments, in particular to frequently used V<sub>κ</sub> genes, thereby increasing their accessibility for recombination (see <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7E</xref> for a model of pre-BCR signaling-induced changes in Igκ locus accessibility).</p>
<p>In this context, our 3C-seq data show that the two κ enhancer elements have distinct roles. Both 3′Eκ and iEκ elements manifest interaction specificity for highly used, E2a-marked, V<sub>κ</sub> genes. However, whereas iEκ already shows this specificity in pro-B cells (although pre-BCR signaling does augment this specificity), 3′Eκ only does so in pre-B cells upon pre-BCR signaling. These observations indicate that iEκ is already “prefocused” at the pro-B cell stage and that pre-BCR signals are required to fully activate and focus the 3′Eκ to allow synergistic promotion of <italic>Igκ</italic> recombination by both enhancers (see <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7E</xref>) <xref ref-type="bibr" rid="pbio.1001791-Inlay2">[52]</xref>. In agreement with such distinct sequential roles, iEκ and not the 3′Eκ was found to be required for the initial increase in <italic>Igκ locus</italic> accessibility, which occurred upon binding of E2a only <xref ref-type="bibr" rid="pbio.1001791-Inlay1">[37]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Lazorchak1">[38]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Inlay3">[67]</xref>. The 3′Eκ on the other hand requires binding of pre-BCR signaling-induced Irf4 to promote locus accessibility <xref ref-type="bibr" rid="pbio.1001791-Johnson1">[19]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Lazorchak1">[38]</xref>, followed by further recruitment of E2a to both κ enhancers and highly used V<sub>κ</sub> genes (<xref ref-type="supplementary-material" rid="pbio.1001791.s012">Table S3</xref> and <xref ref-type="bibr" rid="pbio.1001791-Lazorchak1">[38]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Sakamoto1">[57]</xref>).</p>
<p>The Sis regulatory element was shown to dampen proximal V<sub>κ</sub>–J<sub>κ</sub> rearrangements and to specify the targeting of <italic>Igκ</italic> transgenes to centromeric heterochromatin in pre-B cells <xref ref-type="bibr" rid="pbio.1001791-Liu1">[20]</xref>. As Sis is extensively occupied by the architectural Ctcf protein and deletion of Sis or Ctcf both resulted in increased proximal V<sub>κ</sub> usage <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Xiang1">[23]</xref>, it was postulated that Sis functions as a barrier element to prevent the <italic>κ</italic> enhancers from too frequently targeting proximal V<sub>κ</sub> genes for recombination. In this context, we now provide evidence that interactions between the proximal V<sub>κ</sub> genes, Sis, and iEκ—but not 3′κ—are already coordinated before pre-BCR signaling occurs (<xref ref-type="supplementary-material" rid="pbio.1001791.s009">Figure S9</xref>). Perhaps not surprisingly, Sis-mediated long-range chromatin interactions displayed a pattern and pre-BCR signaling response that was different from the κ enhancers. Unlike for the enhancers, upon pre-BCR signaling, Sis-mediated interactions with regions outside the <italic>Igκ</italic> locus were maintained and interaction within the V<sub>κ</sub> region increased, irrespective of the presence of V<sub>κ</sub> genes or TF binding sites. Because Sis is involved in targeting the nonrecombining <italic>Igκ</italic> allele to heterochromatin <xref ref-type="bibr" rid="pbio.1001791-Liu1">[20]</xref>, the observed interaction pattern of the Sis element might reflect its action in pre-B cells to sequester the nonrecombining <italic>Igκ</italic> locus and target it towards heterochromatin. This might also explain the increased interaction frequencies of Sis with highly used V<sub>κ</sub> genes upon pre-BCR signaling (<xref ref-type="fig" rid="pbio-1001791-g005">Figures 5C</xref> and <xref ref-type="fig" rid="pbio-1001791-g007">7C</xref>), as such highly accessible genes likely require an even tighter association with Sis and heterochromatin to prevent undue recombination.</p>
<p>Surprisingly, we observed a striking correlation between Ikaros binding and V<sub>κ</sub> gene location (94% of V<sub>κ</sub> genes were in close proximity to an Ikaros binding site; <xref ref-type="fig" rid="pbio-1001791-g007">Figure 7A</xref>). Although Ikaros and Aiolos have a positive role in regulating gene expression during B-cell development <xref ref-type="bibr" rid="pbio.1001791-FerreirosVidal1">[55]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Heizmann1">[58]</xref> and Ikaros is required for <italic>IgH</italic> and <italic>IgL</italic> recombination <xref ref-type="bibr" rid="pbio.1001791-Reynaud1">[39]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Heizmann1">[58]</xref>, Ikaros has also been reported to silence gene expression through its association with pericentromeric heterochromatin <xref ref-type="bibr" rid="pbio.1001791-Brown1">[68]</xref> or through recruitment of repressive cofactor complexes <xref ref-type="bibr" rid="pbio.1001791-Kim1">[69]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Koipally1">[70]</xref>. Recruitment of Ikaros to the <italic>Igκ</italic> locus was found increased in pre-B cells as compared to pro-B cells <xref ref-type="bibr" rid="pbio.1001791-Goldmit1">[63]</xref>, in agreement with its up-regulation in pre-B cells (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref>). Furthermore, Ikaros binds the Sis element, where it was suggested to mediate heterochromatin targeting of <italic>Igκ</italic> alleles by the Sis region <xref ref-type="bibr" rid="pbio.1001791-Liu1">[20]</xref>. Aiolos, although not essential for B-cell development like Ikaros <xref ref-type="bibr" rid="pbio.1001791-Heizmann1">[58]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Schmitt1">[71]</xref>, is strongly induced by pre-B cell signaling and has been reported to cooperate with Ikaros in regulation gene expression <xref ref-type="bibr" rid="pbio.1001791-Thompson1">[27]</xref>. Although their synergistic role during <italic>IgL</italic> chain recombination has not been extensively studied, the Ikaros/Aiolos ratio changes upon pre-BCR signaling (<xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref>). Increased recruitment of Ikaros/Aiolos to V<sub>κ</sub> genes and the κ enhancers likely increases Igκ locus accessibility and contraction (see <xref ref-type="fig" rid="pbio-1001791-g006">Figure 6</xref>), as Ikaros was very recently shown to be essential for <italic>IgL</italic> recombination <xref ref-type="bibr" rid="pbio.1001791-Heizmann1">[58]</xref>. On the other hand, it is conceivable that on the nonrecombining allele, increased recruitment of Ikaros/Aiolos to V<sub>κ</sub> genes and the Sis region could facilitate silencing of this allele. Further investigations using allele-specific approaches <xref ref-type="bibr" rid="pbio.1001791-Holwerda1">[72]</xref> will be required to clarify the allele-specific action of the Sis element during <italic>Igκ</italic> recombination.</p>
<p>In summary, by investigating the effects of a pre-BCR signaling gradient—rather than deleting individual TFs—we have taken a more integrative approach to study the regulation of <italic>Igκ</italic> locus topology. Our 3C-Seq analyses in wild-type, Btk, and Slp65 single- and double-deficient pre-B cells show that interaction frequencies between Sis, iEκ, or 3′ Eκ and the V<sub>κ</sub> region are already high in pro-B cells and that pre-BCR signaling induces accessibility through a functional redistribution of long-range chromatin interactions within the V<sub>κ</sub> region, whereby the iEκ and 3′Eκ enhancer elements play distinct roles.</p>
</sec><sec id="s4" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s4a">
<title>Mice</title>
<p>VH81x transgenic mice <xref ref-type="bibr" rid="pbio.1001791-Martin1">[73]</xref> on the <italic>Rag-1</italic><sup>−/−</sup> background <xref ref-type="bibr" rid="pbio.1001791-Mombaerts1">[74]</xref> that were either wild-type, <italic>Btk</italic><sup>−/−</sup> <xref ref-type="bibr" rid="pbio.1001791-Hendriks2">[75]</xref>, <italic>Slp65</italic><sup>−/−</sup> <xref ref-type="bibr" rid="pbio.1001791-Jumaa1">[42]</xref>, or <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> have been previously described <xref ref-type="bibr" rid="pbio.1001791-Kersseboom1">[34]</xref>. Mice were crossed on the C57BL/6 background for &gt;8 generations, bred, and maintained in the Erasmus MC animal care facility under specific pathogen-free conditions and were used at 6–13 wk of age. Experimental procedures were reviewed and approved by the Erasmus University Committee of Animal Experiments.</p>
</sec><sec id="s4b">
<title>Flow Cytometry</title>
<p>Preparation of single-cell suspensions and incubations with monoclonal antibodies (mAbs) were performed using standard procedures. Bone marrow B-lineage cells were purified using fluorescein isothiocyanate (FITC)-conjugated anti-B220(RA3-6B2) and peridinin chlorophyll protein (PCP)-conjugated anti-CD19, together with biotinylated mAbs specific for lineage markers Gr-1, Ter119, and CD11b and APC-conjugated streptavidin as a second step to further exclude non-B cells. Cells were sorted with a FACSARia (BD Biosciences). The following mAbs were used for flow cytometry: FITC-, PerCP–anti-B220 (RA3-6B2), phycoerythrin (PE)–anti-CD2 (LFA-2), PCP-, allophycocyanin (APC)- or APC–Cy7–anti-CD19 (ID3), PE-, or APC anti-CD43 (S7). All these antibodies were purchased from BD Biosciences or eBiosciences. Samples were acquired on an LSRII flow cytometer (BD Biosciences) and analyzed with FlowJo (Tree Star) and FACSDiva (BD Biosciences) software.</p>
</sec><sec id="s4c">
<title>Quantitative RT-PCR and DNA Microarray Analysis</title>
<p>Extraction of total RNA, reverse-transcription procedures, design of primers, and cDNA amplification have been described previously <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>. Gene expression was analyzed using an ABI Prism 7300 Sequence Detector and ABI Prism Sequence Detection Software version 1.4 (Applied Biosystems). All PCR primers used for quantitative RT-PCR of TFs or κ<sup>0</sup>, λ<sup>0</sup>, and V<sub>κ</sub> GLT are described in <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>, except for Obf1 (forward <named-content content-type="gene" xlink:type="simple">5′-CCTGGCCACCTACAGCAC-3′</named-content>, reverse <named-content content-type="gene" xlink:type="simple">5′-GTGGAAGCAGAAA CCTCCAT-3′</named-content>, obtained from the Roche Universal Probe Library).</p>
<p>Biotin-labeled cRNA was hybridized to the Mouse Gene 1.0 ST Array according to the manufacturer's instructions (Affymetrix); data were analyzed with BRB-ArrayTools (version 3.7.0, National Cancer Institute) using Affymetrix CEL files obtained from GCOS (Affymetrix). The RMA approach was used for normalization. The TIGR MultiExperiment Viewer software package (MeV version 4.8.1) was used to perform data analysis and visualize results <xref ref-type="bibr" rid="pbio.1001791-Saeed1">[45]</xref>. One-way ANOVA analysis of the five experimental groups of B cells was used to identify genes significantly different from wild-type VH81X Tg <italic>Rag1</italic><sup>−/−</sup> pre-B cells (<italic>p</italic>&lt;0.01).</p>
</sec><sec id="s4d">
<title>Chromatin Immunoprecipitation (ChIP)</title>
<p>ChIP experiments were performed as previously described <xref ref-type="bibr" rid="pbio.1001791-Stadhouders2">[76]</xref> using FACS sorted bone marrow pre-B cell fractions (0.3–2.0 million cells per ChIP). Antibodies against E2a (sc-349, Santa Cruz Biotechnology) and Ikaros (sc-9861, Santa Cruz Biotechnology) were used for immunoprecipitation. Purified DNA was analyzed by quantitative RT-PCR as described above. Primer sequences are available on request.</p>
</sec><sec id="s4e">
<title>Chromosome Conformation Capture Coupled to High-Throughput Sequencing (3C-Seq)</title>
<p>3C-Seq experiments were essentially carried out as described previously <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Stadhouders1">[41]</xref>. For 3C-Seq library preparation, BglII was used as the primary restriction enzyme and NlaIII as a secondary restriction enzyme. 3C-seq template was prepared from WT E13.5 fetal liver erythroid progenitors and FACS-sorted bone marrow pro-B cell or pre-B cell fractions (see above) from pools of 4–6 mice. In total, between 1 and 8 million cells were used for 3C-seq analysis. Primers for the Sis, iEκ, and 3′Eκ viewpoint-specific inverse PCR were described previously <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref>. 3C-seq libraries were sequenced on an Illumina Hi-Seq 2000 platform. 3C-Seq data processing was performed as described elsewhere <xref ref-type="bibr" rid="pbio.1001791-Stadhouders1">[41]</xref>,<xref ref-type="bibr" rid="pbio.1001791-Thongjuea1">[77]</xref>. Two replicate experiments were sequenced for each genotype and viewpoint, and normalized interaction frequencies per BglII restriction fragment were averaged between the two experiments.</p>
<p>For quantitative analysis, the <italic>Igκ</italic> locus and surrounding sequences were divided into three parts (mm9 genome build): a ∼2 Mb upstream region (chr6:65,441,978–67,443,029; 759 fragments), a ∼3.2 Mb V<sub>κ</sub> region (chr6:67,443,034–70,801,754; 1,290 fragments) and a downstream ∼3.2 Mb region (chr6:70,801,759–73,993,074; 1,143 fragments). For each cell type (as described above) sequence read counts within individual BglII restriction fragments were normalized for differences in library size (expressed as “reads per million”; see <xref ref-type="bibr" rid="pbio.1001791-Mombaerts1">[74]</xref>) and averaged between the two replicates before further use in the various calculations. Very small BglII fragments (&lt;100 bp) were excluded from the analysis. Fragments in the immediate vicinity of the regulatory elements (chr6:70,659,392–70,693,183; 10 fragments) were also excluded because of high levels of noise around the viewpoint, a characteristic of all 3C-based experiments. V<sub>κ</sub> gene coordinates (both functional genes and pseudogenes) were obtained from IMGT <xref ref-type="bibr" rid="pbio.1001791-Lefranc1">[11]</xref> and NCBI (Gene ID: 243469) databases. V<sub>κ</sub> gene usage data (C57BL/6 strain, bone marrow) were obtained from <xref ref-type="bibr" rid="pbio.1001791-AokiOta1">[54]</xref>. ChIP-seq datasets were obtained from <xref ref-type="bibr" rid="pbio.1001791-RibeirodeAlmeida1">[21]</xref> (Ctcf), <xref ref-type="bibr" rid="pbio.1001791-FerreirosVidal1">[55]</xref> (Ikaros), and <xref ref-type="bibr" rid="pbio.1001791-Lin2">[56]</xref> (E2a, H3K4Me2, and H3K4Me3). V<sub>κ</sub> genes were scored positive for TF binding sites or for a histone modification, if they were located on the same BglII restriction fragment (corresponding to the 3C-Seq analysis).</p>
</sec><sec id="s4f">
<title>3D DNA Immuno-FISH</title>
<p><italic>Rag-1</italic><sup>−/−</sup> pro-B and <italic>Rag-1</italic><sup>−/−</sup>;VH81X pre-B cells were isolated from femoral bone marrow suspensions by positive enrichment of CD19<sup>+</sup> cells using magnetic separation (Miltenyi Biotec). Cells were cultured for 2 wk in Iscove's Modified Dulbecco's medium containing 10% fetal calf serum, 200 U/ml penicillin, 200 mg/ml streptomycin, 4 nM L-glutamine, and 50 µM β-mercaptoethanol, supplemented with IL-7 and stem cell factor at 2 ng/ml. <italic>E2a</italic><sup>−/−</sup> hematopoietic progenitors were grown as described previously <xref ref-type="bibr" rid="pbio.1001791-Ikawa1">[78]</xref>. Prior to 3D-FISH analysis, cells were characterized by flow cytometric analysis of CD43, CD19, and CD2 surface marker expression to verify their phenotype (<xref ref-type="supplementary-material" rid="pbio.1001791.s006">Figure S6</xref>).</p>
<p>3D DNA FISH was performed as described previously <xref ref-type="bibr" rid="pbio.1001791-Sayegh1">[79]</xref> with BAC clones RP23-234A12 and RP23-435I4 (located at the distal end of the V<sub>κ</sub> region and at the C<sub>κ</sub>/enhancer region, respectively; <xref ref-type="fig" rid="pbio-1001791-g003">Figure 3A</xref>) obtained from BACPAC Resources (Oakland, CA). Probes were directly labeled with Chromatide Alexa Fluor 488-5 dUTP and Chromatide Alexa Fluor 568-5 dUTP (Invitrogen) using Nick Translation Mix (Roche Diagnostics GmbH).</p>
<p>Cultured primary cells were fixed in 4% paraformaldehyde, and permeabilized in a PBS/0.1% Triton X-100/0.1% saponin solution and subjected to liquid nitrogen immersion following incubation in PBS with 20% glycerol. The nuclear membranes were permeabilized in PBS/0.5% Triton X-100/0.5% saponin prior to hybridization with the DNA probe cocktail. Coverslips were sealed and incubated for 48 h at 37°C, washed, and mounted on slides with 10 µl of Prolong gold anti-fade reagent (Invitrogen).</p>
<p>Pictures were captured with a Leica SP5 confocal microscope (Leica Microsystems). Using a 63× lens (NA 1.4), we acquired images of ∼70 serial optical sections spaced by 0.15 µm. The datasets were deconvolved and analyzed with Huygens Professional software (Scientific Volume Imaging, Hilversum, the Netherlands). The 3D coordinates of the center of mass of each probe were transferred to Microsoft Excel, and the distances separating each probe were calculated using the equation: √(Xa−Xb)2+(Ya−Yb)2+(Za−Zb)2, where X, Y, and Z are the coordinates of object a or b.</p>
</sec><sec id="s4g">
<title>Statistical Analysis</title>
<p>Statistical significance was analyzed using a nonparametric Mann–Whitney U test (IBM SPSS Statistics 20). The <italic>p</italic> values&lt;0.05 were considered significant.</p>
</sec><sec id="s4h">
<title>Accession Numbers</title>
<p>3C-seq and microarray expression datasets have been submitted to the Sequence Read Archive (SRA, accession number SRP032509) and Gene Expression Omnibus (GEO, accession number GSE53896), respectively.</p>
</sec></sec><sec id="s5">
<title>Supporting Information</title>
<supplementary-material id="pbio.1001791.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Gene distance matrix analysis using gene expression profiling data from pre-B/pro-B cell fractions representing a pre-BCR signaling gradient.</bold> Microarray expression profiling was performed on three or four independent FACS-purified B220<sup>+</sup>CD19<sup>+</sup> pre-B cell fractions from wild-type (WT), <italic>Btk</italic>, and <italic>Slp65</italic> single- and double-deficient VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> mice (see <xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref> for gating strategy). The TIGR Multi Experiment Viewer software package (MeV version 4.8.1) was used to perform a one-way ANOVA analysis (<italic>p</italic>&lt;0.01) and identify genes differentially expressed within the five B-cell fractions (versus VH81X Tg <italic>Rag1</italic><sup>−/−</sup> pre-B cells). The software was subsequently used to create a gene distance matrix of highly significant genes, resulting in the depicted plot. Differences in gene expression profiles are depicted as a color code; darker colors indicate greater similarity, and brighter colors less similarity between groups. Consistent with the unsupervised clustering analysis shown in <xref ref-type="fig" rid="pbio-1001791-g001">Figure 1B</xref>, a clear gene expression gradient among the five B cell groups emerges in which <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B and <italic>Rag1</italic><sup>−/−</sup> pro-B cells show highly comparably expression signatures.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Locus-wide 3C-Seq analysis of the </bold><bold><italic>Ig</italic></bold><bold>κ region (Sis viewpoint) plotted as line graphs.</bold> Overview of long-range interactions revealed by 3C-Seq experiments performed on the indicated cell fractions, representing a gradient of pre-BCR signaling. Shown are the relative interaction frequencies (average of two replicate experiments) for the Sis viewpoint per 100 kb region across the <italic>Ig</italic>κ locus, plotted as line graphs. The bottom graph shows an overlay of the WT and <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cell interaction frequencies. The ∼8.4 Mb region containing the <italic>Ig</italic>κ locus (yellow shading) and flanking regions (cyan shading) is depicted. Pre-B cell fractions were FACS-purified from the indicated mice on a VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> background (see <xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref> for gating strategy).</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Locus-wide 3C-Seq analysis of the </bold><bold><italic>Ig</italic></bold><bold>κ region (iEκ viewpoint) plotted as line graphs.</bold> Overview of long-range interactions revealed by 3C-Seq experiments performed on the indicated cell fractions, representing a gradient of pre-BCR signaling. Shown are the relative interaction frequencies (average of two replicate experiments) for the iEκ viewpoint per 100 kb region across the <italic>Ig</italic>κ locus, plotted as line graphs. The bottom graph shows an overlay of the WT and <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cell interaction frequencies. The ∼8.4 Mb region containing the <italic>Ig</italic>κ locus (yellow shading) and flanking regions (cyan shading) is depicted. Pre-B cell fractions were FACS-purified from the indicated mice on a VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> background (see <xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref> for gating strategy).</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s004" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>Locus-wide 3C-Seq analysis of the </bold><bold><italic>Ig</italic></bold><bold>κ region (3′Eκ viewpoint) plotted as line graphs.</bold> Overview of long-range interactions revealed by 3C-Seq experiments performed on the indicated cell fractions, representing a gradient of pre-BCR signaling. Shown are the relative interaction frequencies (average of two replicate experiments) for the 3′Eκ viewpoint per 100 kb region across the <italic>Ig</italic>κ locus, plotted as line graphs. The bottom graph shows an overlay of the WT and <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cell interaction frequencies. The ∼8.4 Mb region containing the <italic>Ig</italic>κ locus (yellow shading) and flanking regions (cyan shading) is depicted. Pre-B cell fractions were FACS-purified from the indicated mice on a VH81x transgenic <italic>Rag1</italic><sup>−/−</sup> background (see <xref ref-type="fig" rid="pbio-1001791-g001">Figure 1</xref> for gating strategy).</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s005" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s005" position="float" xlink:type="simple"><label>Figure S5</label><caption>
<p><bold>Selected zoom-in pictures of the 3C-seq data in the </bold><bold><italic>Ig</italic></bold><bold>κ locus and its upstream and downstream regions.</bold> (A) Map of the ∼8.4 Mb genomic region containing the <italic>Ig</italic>κ locus (yellow shading) and flanking regions (cyan shading). Chromosomal coordinates and gene and viewpoint locations are also depicted. Locations of the zoom-in regions shown in (B) are represented as colored rectangles (red, upstream; green, downstream; dark grey, <italic>Ig</italic>κ locus). (B) Average interaction frequencies per BglII fragment (average of two replicate experiments) of the three regulatory elements with selected regions upstream, downstream, and within the <italic>Ig</italic>κ locus. Data from the five B cell precursor fractions representing a pre-BCR signaling gradient are shown. Complete locus-wide 3C-seq data can be found in <xref ref-type="fig" rid="pbio-1001791-g003">Figure 3</xref> (plotted per individual BglII fragment) or Figures S2, S3, and S4 (plotted per 100 kb region). enh., enhancers.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s006" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s006" position="float" xlink:type="simple"><label>Figure S6</label><caption>
<p><bold>Phenotypic characterization of cultured pre-pro-B, pro-B, and pre-B cells.</bold> Representative FACS analysis of CD43/CD19 (A) and CD2/CD19 (B) surface marker expression on IL-7 cultured <italic>E2a</italic><sup>−/−</sup> pre-pro-B, <italic>Rag1</italic><sup>−/−</sup> pro-B, and VH81x <italic>Rag1</italic><sup>−/−</sup> pre-B cells prior to 3D-FISH experiments.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s007" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s007" position="float" xlink:type="simple"><label>Figure S7</label><caption>
<p><bold>Pre-BCR signaling is associated with an increase in the ratio of interactions inside the </bold><bold><italic>Ig</italic></bold><bold>κ locus over interactions outside the </bold><bold><italic>Ig</italic></bold><bold>κ locus.</bold> The differential effects of pre-BCR signaling on long-range chromatin interactions of the iEκ, 3′Eκ, and Sis elements, as measured in 3C-seq datasets, were quantified (see <xref ref-type="fig" rid="pbio-1001791-g004">Figure 4A</xref>). For all three regulatory elements, the <italic>y</italic>-axis shows the ratio of the average interaction frequencies per BglII fragment inside the ∼3.2 Mb <italic>Igκ</italic> locus over the average interaction frequencies per BglII fragment in the flanking regions (∼2.0 Mb upstream together with 3.2 Mb downstream). Analyses of the five groups of B cell precursors, representing a gradient of pre-BCR signaling, are shown, revealing that pre-BCR signaling is associated with a preference for interaction with fragments inside the V<sub>κ</sub> region over fragments outside the V<sub>κ</sub> region.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s008" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s008" position="float" xlink:type="simple"><label>Figure S8</label><caption>
<p><bold>Interaction frequencies of κ regulatory elements with nonfunctional V<sub>κ</sub> genes as measured in B cell fractions representing a pre-BCR signaling gradient.</bold> Quantitative analysis of 3C-Seq datasets obtained for the five B cell precursor fractions representing a pre-BCR signaling gradient, using the three indicated κ regulatory elements as viewpoints. Average interaction frequencies within the V<sub>κ</sub> region were determined for fragments that do not contain any V<sub>κ</sub> gene (<italic>“no V<sub>κ</sub>”</italic>), those that contain a nonfunctional V<sub>κ</sub> gene (<italic>“pseudo V<sub>κ</sub>”</italic>), and those that contain a functional V<sub>κ</sub> gene (<italic>“functional V<sub>κ</sub>”</italic>). See <xref ref-type="sec" rid="s4">Materials and Methods</xref> section for more details on analysis methods. Statistical significance was determined using a Mann–Whitney U test (n.s., not significant, <italic>p</italic>≥0.05).</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s009" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pbio.1001791.s009" position="float" xlink:type="simple"><label>Figure S9</label><caption>
<p><bold>Correlations between the V<sub>κ</sub> interaction profiles of the three κ regulatory elements.</bold> Correlation plots of average interaction frequencies of the three regulatory elements with the 101 functional V<sub>κ</sub> genes (A) or only the V<sub>κ</sub>3 gene family (B) are shown for WT pre-B cells (top, gray labels) versus <italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells (bottom, yellow labels). Note that under conditions of low pre-BCR signaling (<italic>Btk</italic><sup>−/−</sup><italic>Slp65</italic><sup>−/−</sup> pre-B cells) correlation strength is significantly reduced, with the exception of the correlation between de V<sub>κ</sub>3 interaction profiles of the Sis and iEκ elements.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s010" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pbio.1001791.s010" position="float" xlink:type="simple"><label>Table S1</label><caption>
<p><bold>Genes down-regulated in the absence of Btk and Slp65.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s011" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pbio.1001791.s011" position="float" xlink:type="simple"><label>Table S2</label><caption>
<p><bold>Genes up-regulated in the absence of Btk and Slp65.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material><supplementary-material id="pbio.1001791.s012" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pbio.1001791.s012" position="float" xlink:type="simple"><label>Table S3</label><caption>
<p><bold>Binding of E2a and Ikaros to the κ enhancers and V<sub>κ</sub> genes in wild-type and Btk or Slp65-deficient pre-B cells.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back>
<ack>
<p>We thank H. Jumaa (Ulm, Germany), J. Kearney (Birmingham, AL), and C. Murre (San Diego, CA) for kindly providing <italic>Slp65</italic><sup>−/−</sup>, VH81x transgenic, and <italic>E2a</italic><sup>−/−</sup> mice, respectively. We thank D. Nemazee (La Jolla, CA) for providing detailed V<sub>κ</sub> usage data. We also thank Z. Özgür, C.E.M. Kockx, Rutger Brouwer, and Mirjam van den Hout (Biomics, Erasmus MC), M. Pescatori (Bioinformatics, Erasmus MC), and P.F. van Loo, I. Bergen, and V. Ta (Pulmonary Medicine, Erasmus MC) for their contributions.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="pbio.1001791-Jung1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jung</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Giallourakis</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mostoslavsky</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name> (<year>2006</year>) <article-title>Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus</article-title>. <source>Annu Rev Immunol</source> <volume>24</volume>: <fpage>541</fpage>–<lpage>570</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Bossen1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bossen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mansson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Murre</surname><given-names>C</given-names></name> (<year>2012</year>) <article-title>Chromatin topology and the regulation of antigen receptor assembly</article-title>. <source>Annu Rev Immunol</source> <volume>30</volume>: <fpage>337</fpage>–<lpage>356</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Herzog1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herzog</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Reth</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Jumaa</surname><given-names>H</given-names></name> (<year>2009</year>) <article-title>Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling</article-title>. <source>Nat Rev Immunol</source> <volume>9</volume>: <fpage>195</fpage>–<lpage>205</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Hendriks1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hendriks</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Middendorp</surname><given-names>S</given-names></name> (<year>2004</year>) <article-title>The pre-BCR checkpoint as a cell-autonomous proliferation switch</article-title>. <source>Trends Immunol</source> <volume>25</volume>: <fpage>249</fpage>–<lpage>256</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Jhunjhunwala1"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jhunjhunwala</surname><given-names>S</given-names></name>, <name name-style="western"><surname>van Zelm</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Peak</surname><given-names>MM</given-names></name>, <name name-style="western"><surname>Murre</surname><given-names>C</given-names></name> (<year>2009</year>) <article-title>Chromatin architecture and the generation of antigen receptor diversity</article-title>. <source>Cell</source> <volume>138</volume>: <fpage>435</fpage>–<lpage>448</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Ji1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ji</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Resch</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Corbett</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Yamane</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Casellas</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The in vivo pattern of binding of RAG1 and RAG2 to antigen receptor loci</article-title>. <source>Cell</source> <volume>141</volume>: <fpage>419</fpage>–<lpage>431</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Perlot1"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Perlot</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name> (<year>2008</year>) <article-title>Cis-regulatory elements and epigenetic changes control genomic rearrangements of the IgH locus</article-title>. <source>Adv Immunol</source> <volume>99</volume>: <fpage>1</fpage>–<lpage>32</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Cobb1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cobb</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Oestreich</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Osipovich</surname><given-names>OA</given-names></name>, <name name-style="western"><surname>Oltz</surname><given-names>EM</given-names></name> (<year>2006</year>) <article-title>Accessibility control of V(D)J recombination</article-title>. <source>Adv Immunol</source> <volume>91</volume>: <fpage>45</fpage>–<lpage>109</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Oestreich1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oestreich</surname><given-names>KJ</given-names></name>, <name name-style="western"><surname>Cobb</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Pierce</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Ferrier</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Regulation of TCRbeta gene assembly by a promoter/enhancer holocomplex</article-title>. <source>Immunity</source> <volume>24</volume>: <fpage>381</fpage>–<lpage>391</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Seitan1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Seitan</surname><given-names>VC</given-names></name>, <name name-style="western"><surname>Krangel</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Merkenschlager</surname><given-names>M</given-names></name> (<year>2012</year>) <article-title>Cohesin, CTCF and lymphocyte antigen receptor locus rearrangement</article-title>. <source>Trends Immunol</source> <volume>33</volume>: <fpage>153</fpage>–<lpage>159</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Lefranc1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lefranc</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Giudicelli</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kaas</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Duprat</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jabado-Michaloud</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>IMGT, the international ImMunoGeneTics information system</article-title>. <source>Nucleic Acids Res</source> <volume>33</volume>: <fpage>D593</fpage>–<lpage>597</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Yancopoulos1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yancopoulos</surname><given-names>GD</given-names></name>, <name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name> (<year>1985</year>) <article-title>Developmentally controlled and tissue-specific expression of unrearranged VH gene segments</article-title>. <source>Cell</source> <volume>40</volume>: <fpage>271</fpage>–<lpage>281</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Abarrategui1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abarrategui</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Krangel</surname><given-names>MS</given-names></name> (<year>2009</year>) <article-title>Germline transcription: a key regulator of accessibility and recombination</article-title>. <source>Adv Exp Med Biol</source> <volume>650</volume>: <fpage>93</fpage>–<lpage>102</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Schlissel1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlissel</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>1989</year>) <article-title>Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription</article-title>. <source>Cell</source> <volume>58</volume>: <fpage>1001</fpage>–<lpage>1007</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Murre1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Murre</surname><given-names>C</given-names></name> (<year>2005</year>) <article-title>Helix-loop-helix proteins and lymphocyte development</article-title>. <source>Nat Immunol</source> <volume>6</volume>: <fpage>1079</fpage>–<lpage>1086</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Muljo1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Muljo</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Schlissel</surname><given-names>MS</given-names></name> (<year>2003</year>) <article-title>A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines</article-title>. <source>Nat Immunol</source> <volume>4</volume>: <fpage>31</fpage>–<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Lu1"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Medina</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Lancki</surname><given-names>DW</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>H</given-names></name> (<year>2003</year>) <article-title>IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development</article-title>. <source>Genes Dev</source> <volume>17</volume>: <fpage>1703</fpage>–<lpage>1708</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Ma1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Turetsky</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Trinh</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>R</given-names></name> (<year>2006</year>) <article-title>IFN regulatory factor 4 and 8 promote Ig light chain kappa locus activation in pre-B cell development</article-title>. <source>J Immunol</source> <volume>177</volume>: <fpage>7898</fpage>–<lpage>7904</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Johnson1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Johnson</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hashimshony</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sawai</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Pongubala</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Skok</surname><given-names>JA</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling</article-title>. <source>Immunity</source> <volume>28</volume>: <fpage>335</fpage>–<lpage>345</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Liu1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Widlak</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Zou</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>A recombination silencer that specifies heterochromatin positioning and ikaros association in the immunoglobulin kappa locus</article-title>. <source>Immunity</source> <volume>24</volume>: <fpage>405</fpage>–<lpage>415</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-RibeirodeAlmeida1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ribeiro de Almeida</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></name>, <name name-style="western"><surname>de Bruijn</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Bergen</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Thongjuea</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>The DNA-binding protein CTCF limits proximal Vkappa recombination and restricts kappa enhancer interactions to the immunoglobulin kappa light chain locus</article-title>. <source>Immunity</source> <volume>35</volume>: <fpage>501</fpage>–<lpage>513</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-RibeirodeAlmeida2"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ribeiro de Almeida</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thongjuea</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Soler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Hendriks</surname><given-names>RW</given-names></name> (<year>2012</year>) <article-title>DNA-binding factor CTCF and long-range gene interactions in V(D)J recombination and oncogene activation</article-title>. <source>Blood</source> <volume>119</volume>: <fpage>6209</fpage>–<lpage>6218</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Xiang1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xiang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Hewitt</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Skok</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Garrard</surname><given-names>WT</given-names></name> (<year>2011</year>) <article-title>A multifunctional element in the mouse Igkappa locus that specifies repertoire and Ig loci subnuclear location</article-title>. <source>J Immunol</source> <volume>186</volume>: <fpage>5356</fpage>–<lpage>5366</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Pan1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pan</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Papasani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hao</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Calamito</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wei</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>YY1 controls Igkappa repertoire and B-cell development, and localizes with condensin on the Igkappa locus</article-title>. <source>EMBO J</source> <volume>32</volume>: <fpage>1168</fpage>–<lpage>1182</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Melchers1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Melchers</surname><given-names>F</given-names></name> (<year>2005</year>) <article-title>The pre-B-cell receptor: selector of fitting immunoglobulin heavy chains for the B-cell repertoire</article-title>. <source>Nat Rev Immunol</source> <volume>5</volume>: <fpage>578</fpage>–<lpage>584</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Li1"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Dordai</surname><given-names>DI</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Desiderio</surname><given-names>S</given-names></name> (<year>1996</year>) <article-title>A conserved degradation signal regulates RAG-2 accumulation during cell division and links V(D)J recombination to the cell cycle</article-title>. <source>Immunity</source> <volume>5</volume>: <fpage>575</fpage>–<lpage>589</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Thompson1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thompson</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>Cobb</surname><given-names>BS</given-names></name>, <name name-style="western"><surname>Sabbattini</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Meixlsperger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Parelho</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Ikaros DNA-binding proteins as integral components of B cell developmental-stage-specific regulatory circuits</article-title>. <source>Immunity</source> <volume>26</volume>: <fpage>335</fpage>–<lpage>344</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Nakayama1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakayama</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Hayashi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Satoh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bundo</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>BLNK suppresses pre-B-cell leukemogenesis through inhibition of JAK3</article-title>. <source>Blood</source> <volume>113</volume>: <fpage>1483</fpage>–<lpage>1492</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Herzog2"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herzog</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Hug</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Meixlsperger</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Paik</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>DePinho</surname><given-names>RA</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>SLP-65 regulates immunoglobulin light chain gene recombination through the PI(3)K-PKB-Foxo pathway</article-title>. <source>Nat Immunol</source> <volume>9</volume>: <fpage>623</fpage>–<lpage>631</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Amin1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Amin</surname><given-names>RH</given-names></name>, <name name-style="western"><surname>Schlissel</surname><given-names>MS</given-names></name> (<year>2008</year>) <article-title>Foxo1 directly regulates the transcription of recombination-activating genes during B cell development</article-title>. <source>Nat Immunol</source> <volume>9</volume>: <fpage>613</fpage>–<lpage>622</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Novobrantseva1"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Novobrantseva</surname><given-names>TI</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>VM</given-names></name>, <name name-style="western"><surname>Pelanda</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Muller</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Rajewsky</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Rearrangement and expression of immunoglobulin light chain genes can precede heavy chain expression during normal B cell development in mice</article-title>. <source>J Exp Med</source> <volume>189</volume>: <fpage>75</fpage>–<lpage>88</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Melchers2"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Melchers</surname><given-names>F</given-names></name>, <name name-style="western"><surname>ten Boekel</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Seidl</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kong</surname><given-names>XC</given-names></name>, <name name-style="western"><surname>Yamagami</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells</article-title>. <source>Immunol Rev</source> <volume>175</volume>: <fpage>33</fpage>–<lpage>46</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Schlissel2"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schlissel</surname><given-names>MS</given-names></name> (<year>2004</year>) <article-title>Regulation of activation and recombination of the murine Igkappa locus</article-title>. <source>Immunol Rev</source> <volume>200</volume>: <fpage>215</fpage>–<lpage>223</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Kersseboom1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kersseboom</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ta</surname><given-names>VB</given-names></name>, <name name-style="western"><surname>Zijlstra</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Middendorp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jumaa</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Bruton's tyrosine kinase and SLP-65 regulate pre-B cell differentiation and the induction of Ig light chain gene rearrangement</article-title>. <source>J Immunol</source> <volume>176</volume>: <fpage>4543</fpage>–<lpage>4552</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Dingjan1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dingjan</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Middendorp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dahlenborg</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Maas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Grosveld</surname><given-names>F</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Bruton's tyrosine kinase regulates the activation of gene rearrangements at the lambda light chain locus in precursor B cells in the mouse</article-title>. <source>J Exp Med</source> <volume>193</volume>: <fpage>1169</fpage>–<lpage>1178</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Roldan1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roldan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Fuxa</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Chong</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Martinez</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Novatchkova</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Locus ‘decontraction’ and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene</article-title>. <source>Nat Immunol</source> <volume>6</volume>: <fpage>31</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Inlay1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inlay</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name> (<year>2004</year>) <article-title>Important roles for E protein binding sites within the immunoglobulin kappa chain intronic enhancer in activating Vkappa Jkappa rearrangement</article-title>. <source>J Exp Med</source> <volume>200</volume>: <fpage>1205</fpage>–<lpage>1211</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Lazorchak1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lazorchak</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Schlissel</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Zhuang</surname><given-names>Y</given-names></name> (<year>2006</year>) <article-title>E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells</article-title>. <source>Mol Cell Biol</source> <volume>26</volume>: <fpage>810</fpage>–<lpage>821</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Reynaud1"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Reynaud</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Demarco</surname><given-names>IA</given-names></name>, <name name-style="western"><surname>Reddy</surname><given-names>KL</given-names></name>, <name name-style="western"><surname>Schjerven</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Bertolino</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros</article-title>. <source>Nat Immunol</source> <volume>9</volume>: <fpage>927</fpage>–<lpage>936</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Lin1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Benner</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mansson</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Heinz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Miyazaki</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Global changes in the nuclear positioning of genes and intra- and interdomain genomic interactions that orchestrate B cell fate</article-title>. <source>Nat Immunol</source> <volume>13</volume>: <fpage>1196</fpage>–<lpage>1204</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Stadhouders1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kolovos</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Brouwer</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Zuin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>van den Heuvel</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Multiplexed chromosome conformation capture sequencing for rapid genome-scale high-resolution detection of long-range chromatin interactions</article-title>. <source>Nat Protoc</source> <volume>8</volume>: <fpage>509</fpage>–<lpage>524</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Jumaa1"><label>42</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jumaa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wollscheid</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Mitterer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wienands</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Reth</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65</article-title>. <source>Immunity</source> <volume>11</volume>: <fpage>547</fpage>–<lpage>554</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Middendorp1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Middendorp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dingjan</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Hendriks</surname><given-names>RW</given-names></name> (<year>2002</year>) <article-title>Impaired precursor B cell differentiation in Bruton's tyrosine kinase-deficient mice</article-title>. <source>J Immunol</source> <volume>168</volume>: <fpage>2695</fpage>–<lpage>2703</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Jumaa2"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jumaa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Mitterer</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Reth</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nielsen</surname><given-names>PJ</given-names></name> (<year>2001</year>) <article-title>The absence of SLP65 and Btk blocks B cell development at the preB cell receptor-positive stage</article-title>. <source>Eur J Immunol</source> <volume>31</volume>: <fpage>2164</fpage>–<lpage>2169</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Saeed1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saeed</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Bhagabati</surname><given-names>NK</given-names></name>, <name name-style="western"><surname>Braisted</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Sharov</surname><given-names>V</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>TM4 microarray software suite</article-title>. <source>Methods Enzymol</source> <volume>411</volume>: <fpage>134</fpage>–<lpage>193</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Kersseboom2"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kersseboom</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Middendorp</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Dingjan</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Dahlenborg</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Reth</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells</article-title>. <source>J Exp Med</source> <volume>198</volume>: <fpage>91</fpage>–<lpage>98</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Bertocci1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bertocci</surname><given-names>B</given-names></name>, <name name-style="western"><surname>De Smet</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Berek</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Weill</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>Reynaud</surname><given-names>CA</given-names></name> (<year>2003</year>) <article-title>Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu</article-title>. <source>Immunity</source> <volume>19</volume>: <fpage>203</fpage>–<lpage>211</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Baldwin1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baldwin</surname><given-names>AS</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>LeClair</surname><given-names>KP</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Sharp</surname><given-names>PA</given-names></name> (<year>1990</year>) <article-title>A large protein containing zinc finger domains binds to related sequence elements in the enhancers of the class I major histocompatibility complex and kappa immunoglobulin genes</article-title>. <source>Mol Cell Biol</source> <volume>10</volume>: <fpage>1406</fpage>–<lpage>1414</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Engel1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Engel</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rolink</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weiss</surname><given-names>S</given-names></name> (<year>1999</year>) <article-title>B cells are programmed to activate kappa and lambda for rearrangement at consecutive developmental stages</article-title>. <source>Eur J Immunol</source> <volume>29</volume>: <fpage>2167</fpage>–<lpage>2176</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Gorman1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gorman</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>van der Stoep</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Monroe</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Cogne</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes</article-title>. <source>Immunity</source> <volume>5</volume>: <fpage>241</fpage>–<lpage>252</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Xu1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Davidson</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name> (<year>1996</year>) <article-title>Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement</article-title>. <source>Immunity</source> <volume>4</volume>: <fpage>377</fpage>–<lpage>385</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Inlay2"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inlay</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Alt</surname><given-names>FW</given-names></name>, <name name-style="western"><surname>Baltimore</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name> (<year>2002</year>) <article-title>Essential roles of the kappa light chain intronic enhancer and 3′ enhancer in kappa rearrangement and demethylation</article-title>. <source>Nat Immunol</source> <volume>3</volume>: <fpage>463</fpage>–<lpage>468</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Greenbaum1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Greenbaum</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhuang</surname><given-names>Y</given-names></name> (<year>2002</year>) <article-title>Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>99</volume>: <fpage>15030</fpage>–<lpage>15035</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-AokiOta1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aoki-Ota</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Torkamani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ota</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Schork</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Nemazee</surname><given-names>D</given-names></name> (<year>2012</year>) <article-title>Skewed primary Igkappa repertoire and V-J joining in C57BL/6 mice: implications for recombination accessibility and receptor editing</article-title>. <source>J Immunol</source> <volume>188</volume>: <fpage>2305</fpage>–<lpage>2315</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-FerreirosVidal1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ferreiros-Vidal</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Carroll</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Terry</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Genome-wide identification of Ikaros targets elucidates its contribution to mouse B-cell lineage specification and pre-B-cell differentiation</article-title>. <source>Blood</source> <volume>121</volume>: <fpage>1769</fpage>–<lpage>1782</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Lin2"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Jhunjhunwala</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Benner</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Heinz</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Welinder</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate</article-title>. <source>Nat Immunol</source> <volume>11</volume>: <fpage>635</fpage>–<lpage>643</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Sakamoto1"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sakamoto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Wakae</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Anzai</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Murai</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tamaki</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>E2A and CBP/p300 act in synergy to promote chromatin accessibility of the immunoglobulin kappa locus</article-title>. <source>J Immunol</source> <volume>188</volume>: <fpage>5547</fpage>–<lpage>5560</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Heizmann1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Heizmann</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Kastner</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals</article-title>. <source>J Exp Med</source> e-pub. December 2013.</mixed-citation>
</ref>
<ref id="pbio.1001791-Feeney1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Feeney</surname><given-names>AJ</given-names></name> (<year>2011</year>) <article-title>Epigenetic regulation of antigen receptor gene rearrangement</article-title>. <source>Curr Opin Immunol</source> <volume>23</volume>: <fpage>171</fpage>–<lpage>177</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Liu2"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Liu</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Subrahmanyam</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Chakraborty</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sen</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Desiderio</surname><given-names>S</given-names></name> (<year>2007</year>) <article-title>A plant homeodomain in RAG-2 that binds Hypermethylated lysine 4 of histone H3 is necessary for efficient antigen-receptor-gene rearrangement</article-title>. <source>Immunity</source> <volume>27</volume>: <fpage>561</fpage>–<lpage>571</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Matthews1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matthews</surname><given-names>AG</given-names></name>, <name name-style="western"><surname>Kuo</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Ramon-Maiques</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Han</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Champagne</surname><given-names>KS</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>RAG2 PHD finger couples histone H3 lysine 4 trimethylation with V(D)J recombination</article-title>. <source>Nature</source> <volume>450</volume>: <fpage>1106</fpage>–<lpage>1110</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Bain1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bain</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Robanus Maandag</surname><given-names>EC</given-names></name>, <name name-style="western"><surname>te Riele</surname><given-names>HP</given-names></name>, <name name-style="western"><surname>Feeney</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Sheehy</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Both E12 and E47 allow commitment to the B cell lineage</article-title>. <source>Immunity</source> <volume>6</volume>: <fpage>145</fpage>–<lpage>154</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Goldmit1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Goldmit</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Skok</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Roldan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Jung</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Epigenetic ontogeny of the Igk locus during B cell development</article-title>. <source>Nat Immunol</source> <volume>6</volume>: <fpage>198</fpage>–<lpage>203</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Degner1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Degner</surname><given-names>SC</given-names></name>, <name name-style="western"><surname>Verma-Gaur</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wong</surname><given-names>TP</given-names></name>, <name name-style="western"><surname>Bossen</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Iverson</surname><given-names>GM</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>108</volume>: <fpage>9566</fpage>–<lpage>9571</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Guo1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Guo</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Franklin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jain</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ebert</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>CTCF-binding elements mediate control of V(D)J recombination</article-title>. <source>Nature</source> <volume>477</volume>: <fpage>424</fpage>–<lpage>430</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Xu2"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Xu</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Feeney</surname><given-names>AJ</given-names></name> (<year>2009</year>) <article-title>The epigenetic profile of Ig genes is dynamically regulated during B cell differentiation and is modulated by pre-B cell receptor signaling</article-title>. <source>J Immunol</source> <volume>182</volume>: <fpage>1362</fpage>–<lpage>1369</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Inlay3"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Inlay</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lin</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Gao</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>Y</given-names></name> (<year>2006</year>) <article-title>Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci</article-title>. <source>J Exp Med</source> <volume>203</volume>: <fpage>1721</fpage>–<lpage>1732</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Brown1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brown</surname><given-names>KE</given-names></name>, <name name-style="western"><surname>Guest</surname><given-names>SS</given-names></name>, <name name-style="western"><surname>Smale</surname><given-names>ST</given-names></name>, <name name-style="western"><surname>Hahm</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Merkenschlager</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin</article-title>. <source>Cell</source> <volume>91</volume>: <fpage>845</fpage>–<lpage>854</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Kim1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sif</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Jackson</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Koipally</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Ikaros DNA-binding proteins direct formation of chromatin remodeling complexes in lymphocytes</article-title>. <source>Immunity</source> <volume>10</volume>: <fpage>345</fpage>–<lpage>355</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Koipally1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koipally</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Renold</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Georgopoulos</surname><given-names>K</given-names></name> (<year>1999</year>) <article-title>Repression by Ikaros and Aiolos is mediated through histone deacetylase complexes</article-title>. <source>EMBO J</source> <volume>18</volume>: <fpage>3090</fpage>–<lpage>3100</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Schmitt1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmitt</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tonnelle</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Dalloul</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Chabannon</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Debre</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Aiolos and Ikaros: regulators of lymphocyte development, homeostasis and lymphoproliferation</article-title>. <source>Apoptosis</source> <volume>7</volume>: <fpage>277</fpage>–<lpage>284</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Holwerda1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Holwerda</surname><given-names>SJ</given-names></name>, <name name-style="western"><surname>van de Werken</surname><given-names>HJ</given-names></name>, <name name-style="western"><surname>Ribeiro de Almeida</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Bergen</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>de Bruijn</surname><given-names>MJ</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Allelic exclusion of the immunoglobulin heavy chain locus is independent of its nuclear localization in mature B cells</article-title>. <source>Nucleic Acids Res</source> <volume>41</volume>: <fpage>6905</fpage>–<lpage>6916</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Martin1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Martin</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Kearney</surname><given-names>JF</given-names></name> (<year>1997</year>) <article-title>Development of VH81X transgene-bearing B cells in fetus and adult: sites for expansion and deletion in conventional and CD5/B1 cells</article-title>. <source>Int Immunol</source> <volume>9</volume>: <fpage>493</fpage>–<lpage>505</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Mombaerts1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mombaerts</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Iacomini</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>RS</given-names></name>, <name name-style="western"><surname>Herrup</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tonegawa</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1992</year>) <article-title>RAG-1-deficient mice have no mature B and T lymphocytes</article-title>. <source>Cell</source> <volume>68</volume>: <fpage>869</fpage>–<lpage>877</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Hendriks2"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hendriks</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>de Bruijn</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Maas</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Dingjan</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Karis</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1996</year>) <article-title>Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage</article-title>. <source>EMBO J</source> <volume>15</volume>: <fpage>4862</fpage>–<lpage>4872</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Stadhouders2"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Thongjuea</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Andrieu-Soler</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Palstra</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Bryne</surname><given-names>JC</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development</article-title>. <source>EMBO J</source> <volume>31</volume>: <fpage>986</fpage>–<lpage>999</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Thongjuea1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thongjuea</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Stadhouders</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Grosveld</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Soler</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Lenhard</surname><given-names>B</given-names></name> (<year>2013</year>) <article-title>r3Cseq: an R/Bioconductor package for the discovery of long-range genomic interactions from chromosome conformation capture and next-generation sequencing data</article-title>. <source>Nucleic Acids Res</source> <volume>41</volume>: <fpage>e132</fpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Ikawa1"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ikawa</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Kawamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wright</surname><given-names>LY</given-names></name>, <name name-style="western"><surname>Murre</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent</article-title>. <source>Immunity</source> <volume>20</volume>: <fpage>349</fpage>–<lpage>360</lpage>.</mixed-citation>
</ref>
<ref id="pbio.1001791-Sayegh1"><label>79</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sayegh</surname><given-names>CE</given-names></name>, <name name-style="western"><surname>Jhunjhunwala</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Riblet</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Murre</surname><given-names>C</given-names></name> (<year>2005</year>) <article-title>Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells</article-title>. <source>Genes Dev</source> <volume>19</volume>: <fpage>322</fpage>–<lpage>327</lpage>.</mixed-citation>
</ref>
</ref-list><glossary><title>Abbreviations</title><def-list><def-item>
<term>3′Eκ</term>
<def>
<p>3′ κ enhancer</p>
</def>
</def-item><def-item>
<term>Btk</term>
<def>
<p>Bruton's tyrosine kinase</p>
</def>
</def-item><def-item>
<term>H3K4me2/3</term>
<def>
<p>histone H3 di- or trimethylated at lysine 4</p>
</def>
</def-item><def-item>
<term>iEκ</term>
<def>
<p>intronic κ enhancer</p>
</def>
</def-item><def-item>
<term>Ig</term>
<def>
<p>Immunoglobulin</p>
</def>
</def-item><def-item>
<term>pre-BCR</term>
<def>
<p>pre–B-cell receptor</p>
</def>
</def-item><def-item>
<term>Sis</term>
<def>
<p>silencer in intervening sequence</p>
</def>
</def-item><def-item>
<term>SLC</term>
<def>
<p>surrogate light chain</p>
</def>
</def-item><def-item>
<term>TF</term>
<def>
<p>transcription factor</p>
</def>
</def-item><def-item>
<term>V<sub>κ</sub></term>
<def>
<p>Igκ variable region</p>
</def>
</def-item></def-list></glossary></back>
</article>